SESSION 1 SCHEDULE
Tuesday
SESSION 1: PROGRESS IN TRANSCATHETER HEART VALVES AND NEW APPROACHES TO ASCENDING AORTIC DISEASE
x
6:49 AM - 6:53 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
  View Abstract      
6:53 AM - 6:58 AM Cerebral Protection Techniques And Devices For Use In Transcatheter Aortic Valve Replacement (TAVR) And TEVAR: The Embrella And Claret Medical Sentinal Devices And Others: How Well Do They Work
  Presenter(s):Jeffrey P. Carpenter, MD  
  View Abstract      
6:59 AM - 7:04 AM Status Of Left Atrial Appendage Occlusive Devices In 2014
  Presenter(s):Ted Feldman, MD  
  View Abstract      
7:05 AM - 7:10 AM Trans-Carotid Access For TAVR: Value, Technique And Limitations
  Presenter(s):Erno Remsey-Semmelweis, MD, PhD  
  View Abstract      
7:11 AM - 7:16 AM Status Of Transcatheter Mitral Valve Repair: Where Is It Heading
  Presenter(s):Ted Feldman, MD  
  View Abstract      
7:17 AM - 7:22 AM Role And Value Of TAVR Today And In The Future
  Presenter(s):Allan Stewart, MD  
  View Abstract      
ASCENDING AORTIC LESIONS
7:23 AM - 7:28 AM New Simplified Concept For Constructing Branched Endografts From Standardized Components: How It Can Be Used For TAAAs, Arch Lesions And Hypogastric Revascularization
  Presenter(s):Patrick W. Kelly, MD  
  View Abstract      
7:29 AM - 7:34 AM Endovascular Approaches To The Ascending Aorta For Repair With A Branched Endograft: Techniques And When Is It Feasible And For What Lesions
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Abstract      
7:35 AM - 7:40 AM Innovative Approaches And Future Horizons To Ascending Aortic Pathologies: What Can Be Done And What Problems Remain
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Abstract      
7:41 AM - 7:46 AM Tips, Tricks And Results With Endograft Repair Of Ascending Aortic Lesions
  Presenter(s):Grayson H. Wheatley, MD / Edward B. Diethrich, MD  
  View Abstract      
7:47 AM - 7:52 AM Hemodynamic And Anatomical Challenges To Overcome With Endovascular Grafts In The Ascending Aorta
  Presenter(s):Robert J. Hinchliffe, MD  
  View Abstract      
7:53 AM - 7:58 AM Experience With Ascending Aortic Endografts Using An FDA IDE Approved Device: What Has Been Done, What Lesions Can Be Treated And What Challenges Remain
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Abstract      
7:59 AM - 8:05 AM Panel Discussion
END OF SESSION 1
 
SESSION 2 SCHEDULE
Tuesday
SESSION 2: NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC ARCH LESIONS AND DISSECTIONS
x
8:06 AM - 8:11 AM For Arch Lesions In Situ Fenestration Is Still Viable: New Techniques Will Facilitate This Approach
  Presenter(s):Bjõrn Sonesson, MD, PhD  
  View Abstract      
8:12 AM - 8:17 AM Results Of Branched Endografts For Repair Of Aortic Arch Lesions: Based On A Chinese Multicenter Study
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Abstract      
8:18 AM - 8:23 AM Mid-Term Outcomes Of A Simplified Method Of Arch Aneurysm Treatment Using A Precurved Fenestrated Aortic Endograft: Technique And Results
  Presenter(s):Yoshihiko Yokoi, MD  
  View Abstract      
MEGADEBATE
8:24 AM - 8:29 AM DEBATE: Total Endovascular Aortic Arch Repair Is Feasible And Will Be The Best Method: Technique And Early Results
  Presenter(s):Stephan Haulon, MD  
  View Abstract      
8:30 AM - 8:35 AM DEBATE: Hybrid (Open And Endo) Repair Is The Best Treatment For Aortic Arch Lesions: Tips And Tricks
  Presenter(s):Germano Melissano, MD  
  View Abstract      
8:36 AM - 8:41 AM DEBATE: Value And Limitations Of Chimney Grafts To Treat Arch Lesions: When Are They Best: Based On An 11-Year Experience
  Presenter(s):Nicola Mangialardi, MD  
  View Abstract      
8:42 AM - 8:47 AM DEBATE: Total Endovascular Arch Replacement With Sandwich Grafts, And TEVAR Is Often The Simplest And Best Treatment For Arch Lesions
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Abstract      
8:48 AM - 8:53 AM DEBATE: Open Repair Is Still The Best Treatment For Most Arch Lesions
  Presenter(s):Joseph S. Coselli, MD  
  View Abstract      
8:54 AM - 8:59 AM Total Endovascular Arch Repair For Arch Aneurysms And Dissections: Comparison Of Bolton Double Branch Endograft vs. Hybrid Debranching With TEVAR
  Presenter(s):Toru Kuratani, MD, PhD  
  View Abstract      
9:00 AM - 9:05 AM A New Classification System For Type B Aortic Dissection (TBAD): It Will Help Predict The Probability Of Visceral Malperfusion And Reverse Aortic Remodeling After TEVAR
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Abstract      
9:06 AM - 9:13 AM Panel Discussion
END OF SESSION 2
 
SESSION 3 SCHEDULE
Tuesday
SESSION 3: TYPE B AORTIC DISSECTIONS (TBADs) AND THEIR TREATMENT
x
9:13 AM - 9:18 AM New MR Imaging Techniques (4D) To Measure Vascular Hemodynamics And Biomechanics: How Can They Help In Treating Patients With TBADs
  Presenter(s):Rachel E. Clough, MD, PhD  
  View Abstract      
9:19 AM - 9:24 AM Tips And Tricks For Avoiding Pitfalls In The TEVAR Treatment Of TBADs: Based On Experience In More Than 1800 Patients
  Presenter(s):Wei Guo Fu, MD  
  View Abstract      
FOUR-WAY DEBATE
9:25 AM - 9:30 AM DEBATE: All “Uncomplicated” TBADs Should Be Treated Early By TEVAR Since All Are Or Will Become Complicated: INSTEAD XL And IRAD Prove It And We Don’t Need Further Trials
  Presenter(s):Christoph A. Nienaber, MD, PhD  
  View Abstract      
9:31 AM - 9:36 AM DEBATE: Why We Still Need A Randomized Controlled Trial (RCT) Of Intensive Medical Therapy vs. Early TEVAR For Uncomplicated TBAD
  Presenter(s):Frank A. Lederle, MD  
  View Abstract      
9:37 AM - 9:42 AM DEBATE: Medical Therapy And Close Observation Is Best For Uncomplicated TBAD: When Complications Arise, Most Patients Are Best Treated With Open Operation: Long-Term Results (>20 Years) Justify It
  Presenter(s):Hazim J. Safi, MD / Ali Azizzadeh, MD  
  View Abstract      
9:43 AM - 9:48 AM DEBATE: With Patients Having Uncomplicated TBAD Medical Treatment With Delayed (2-3 Months) TEVAR Is The Best Treatment: It Will Lessen Complications Including Retrograde Type A Dissections
  Presenter(s):Matt M. Thompson, MD  
  View Abstract      
9:49 AM - 9:54 AM Current Single Center Results Of Medically Treated TBAD Patients
  Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD  
  View Abstract      
9:55 AM - 10:00 AM Why We Need A New Classification System For Patients With TBAD: What Is It
  Presenter(s):Christoph A. Nienaber, MD, PhD / Michael D. Dake, MD  
  View Abstract      
10:01 AM - 10:10 AM Panel Discussion
10:10 AM - 10:30 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 3
 
SESSION 4 SCHEDULE
Tuesday
SESSION 4: NEW DEVELOPMENTS IN TEVAR AND THE MANAGEMENT OF TBAD PATIENTS
x
10:30 AM - 10:35 AM Management Of Distal Re-entry Tears After TEVAR For TBAD: When Is It Necessary And How To Do It
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Abstract      
10:36 AM - 10:41 AM In Patients With Acute TBADs When Is TEVAR Closure Of Proximal Entry Tears Sufficient And When Is Adjunctive Treatment Necessary: What Adjunctive Procedures Can Be Used
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Abstract      
10:42 AM - 10:47 AM Endovascular Options To Obliterate The Patent False Lumen When Coverage Of The Primary Tear Does Not Do So: New Data On Safety And Efficacy Of These Options
  Presenter(s):Peter J. Mossop, MBBS  
  View Abstract      
10:48 AM - 10:53 AM Is The Petticoat Technique (Proximal Covered Stent And Distal Bare Stent) Effective In Treating Acute And Chronic TBADs: 3-Year Results Of The STABLE I And II Trials: Are Long-Term Outcomes Better
  Presenter(s):Joseph V. Lombardi, MD  
  View Abstract      
10:54 AM - 10:59 AM DEBATE: Value And Limitations Of Using Fenestrated And Branched Endografts (F/B EVAR) To Treat Chronic TBADs With Infradiaphragmatic AAAs: It Is The Way To Go
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Piotr M. Kasprzak, MD  
  View Abstract      
11:00 AM - 11:05 AM DEBATE: What Is Wrong With TEVAR To Treat Chronic TBADs
  Presenter(s):Nicholas J.W. Cheshire, MD / Richard G.J. Gibbs, FRCS  
  View Abstract      
11:06 AM - 11:11 AM When After An Acute TBAD Does The Dissection Flap Become Fixed: Based On Dynamic (4D) CTA And MRA
  Presenter(s):Alan B. Lumsden, MD, FACS  
  View Abstract      
11:12 AM - 11:17 AM Objective Assessment Of Current Endografts For TEVAR: Which Grafts For Which Lesion And Which Anatomy: It Makes A Difference
  Presenter(s):Ludovic Canaud, MD, PhD  
  View Abstract      
11:18 AM - 11:25 AM Panel Discussion
Moderator(s): Kim J. Hodgson, MD / Jan S. Brunkwall, MD, PhD  
11:25 AM - 11:30 AM Pathophysiological Mechanism For False Lumen Enlargement To Form An Aneurysm After A TBAD: What Can Be Done To Prevent It
  Presenter(s):Ramon Berguer, MD, PhD  
  View Abstract      
11:31 AM - 11:36 AM Late Remodeling In Stented And Unstented Aortic Segments After TEVAR For Complex TBADs
  Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD  
  View Abstract      
11:37 AM - 11:42 AM Intensive Follow-up With CTA Imaging Surveillance Is Needed For TEVAR To Be Successful Treatment Of TBAD Patients
  Presenter(s):Götz M. Richter, MD, PhD  
  View Abstract      
11:43 AM - 11:48 AM Long-Term (20-Year) Results Of Open Repair Of Chronic TBADs With Aneurysm Formation Are Good: It Should Be The Gold Standard Of Care
  Presenter(s):Hazim J. Safi, MD  
  View Abstract      
11:49 AM - 11:54 AM Branched Endografts For Treating Chronic TBAD With Aneurysm Formation: Advantages And Limitations
  Presenter(s):Marcelo Ferreira, MD  
  View Abstract      
11:55 AM - 0:00 AM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 4
 
SESSION 5 SCHEDULE
Tuesday
SESSION 5: IN HONOR OF JAMES A. DEWEESE, MD: NEW DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
x
1:00 PM - 1:05 PM Tips And Tricks To Make CAS Safer: Lessons Learned After More Than 3000 Procedures
  Presenter(s):Klaus D. Mathias, MD  
  View Abstract      
1:06 PM - 1:11 PM CAS Recanalization For Total ICA Occlusions: Long-Term Clinical And Image Follow-up: When Are The Procedures Worthwhile: A New Horizon
  Presenter(s):Paul H.L. Kao, MD  
  View Abstract      
1:12 PM - 1:17 PM Diagnosis And Prophylactic Treatment Of Vulnerable Plaques: Can Their Vulnerability Be Decreased By Stenting
  Presenter(s):Gregg W. Stone, MD  
  View Abstract      
1:18 PM - 1:23 PM What Is The Current Evidence For Decreasing The Incidence Of Strokes On Medical Treatment Alone: Don’t Believe The NY Times – Statins Are Safe And Should Be Used More Widely
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
  View Abstract      
1:24 PM - 1:29 PM What Constitutes Best Medical Treatment (BMRx) Currently In Asymptomatic Carotid Stenosis: What Happens To Carotid Plaques On BMRx
  Presenter(s):J. David Spence, MD  
  View Abstract      
1:30 PM - 1:35 PM Long-Term Results Of SAMMPRIS Trial In Patients With Intracranial Stenoses: What Does It Tell Us About The Feasibility And Value Of BMRx
  Presenter(s):Colin P. Derdeyn, MD / Marc I. Chimowitz, MBChB  
  View Abstract      
1:36 PM - 1:41 PM Increased Cardiovascular Mortality In Patients With Asymptomatic Carotid Stenosis Who Are Not On Statins: What Should Optimal Medical Therapy Be And Can It Decrease Plaque Size And Danger
  Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD / 
  View Abstract      
1:42 PM - 1:48 PM Panel Discussion
Moderator(s): Daniel G. Clair, MD / Jean-Pierre Becquemin, MD, FRCS  
1:48 PM - 1:53 PM Update On The ACT I Trial: A RCT Comparing CAS vs. CEA In Patients With Asymptomatic High-Grade Carotid Stenosis
  Presenter(s):Jon S. Matsumura, MD  
  View Abstract      
1:54 PM - 1:59 PM DEBATE: Medical Treatment Is Best For Patients With High-Grade Asymptomatic Carotid Stenosis (Asx CS)
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Abstract      
2:00 PM - 2:05 PM DEBATE: Carotid Endarterectomy (CEA) Is The Best Treatment For Most Patients With High-Grade Asx CS
  Presenter(s):Richard P. Cambria, MD  
  View Abstract      
2:06 PM - 2:11 PM DEBATE: Carotid Stenting (CAS) Is The Best Treatment For Most Patients With High-Grade Asx CS
  Presenter(s):William A. Gray, MD  
  View Abstract      
2:12 PM - 2:17 PM Early Results From The ACST-2 Trial: In >1500 Patients CAS And CEA Appear To Be Equivalent Treatments For Asx CS
  Presenter(s):Alison Halliday, MS, FRCS  
  View Abstract      
2:18 PM - 2:23 PM What Will CREST 2 Tell Us And When: We Must Compare CAS And CEA vs. Current Medical Treatment In Patients With Asx CS In A RCT
  Presenter(s):Thomas G. Brott, MD  
  View Abstract      
2:24 PM - 2:29 PM What Will SPACE 2 Tell Us And When: We Must Compare CAS And CEA vs. Current Medical Treatment In Patients With Asx CS In A RCT
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Abstract      
2:26 PM - 2:41 PM DEBATE: Based On The CREST RCT And Other Data, CAS Is The Best Treatment For Most Patients With Sx CS If The Right Techniques Are Used In Experienced Centers
  Presenter(s):Horst Sievert, MD  
  View Abstract      
2:30 PM - 2:35 PM DEBATE: Based On The CREST RCT And Other Data, CEA Seems To Be The Best Treatment For Symptomatic Carotid Stenosis (Sx CS) In Most Patients
  Presenter(s):Wesley S. Moore, MD  
  View Abstract      
2:42 PM - 2:50 PM Panel Discussion
2:50 PM - 3:05 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 5
 
SESSION 6 SCHEDULE
Tuesday
SESSION 6: MORE ON THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
x
3:05 PM - 3:10 PM Resolving The Differences Between Various CAS/CEA Guidelines – All Based On The Same Data: How Could They Be So Different
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Abstract      
3:11 PM - 3:16 PM How To Optimize Brain Safety With CAS And CEA: What Is The Significance Of Silent MRI Defects
  Presenter(s):Laura Capoccia, MD, PhD  
  View Abstract      
3:17 PM - 3:22 PM Microemboli And DW MRI Defects After Carotid Interventions: Do They Impair Cognitive Function
  Presenter(s):Wei Zhou, MD  
  View Abstract      
3:23 PM - 3:28 PM Can Asx CS Lead To Cognitive Impairment: Does Carotid Revascularization Produce Cognitive Improvement
  Presenter(s):Brajesh K. Lal, MD  
  View Abstract      
3:29 PM - 3:34 PM Proximal Brain Protection With Flow Reversal vs. Filter Protection For CAS: Which Is Better And How Best To Achieve Flow Reversal
  Presenter(s):Claudio J. Schonholz, MD  
  View Abstract      
3:35 PM - 3:40 PM Flow Reversal Brain Protection Can Be Achieved During CAS With A Modified Mo.Ma Device: How To Do It
  Presenter(s):Juan C. Parodi, MD  
  View Abstract      
EARLY TREATMENT OF SX CS
3:41 PM - 3:46 PM Is CEA Within 48 Hours Of Acute Symptom Onset Safe: The Evidence Is Mixed
  Presenter(s):Martin Bjorck, MD, PhD  
  View Abstract      
3:47 PM - 3:52 PM CEA Early After Symptom Onset Does Not Increase Risk: Not So With CAS
  Presenter(s):Gustav Fraedrich, MD  
  View Abstract      
3:53 PM - 3:58 PM DEBATE: Expedited CEA In Symptomatic CS Patients: How Long Post Symptom Onset Can Patients Safely Undergo CEA
  Presenter(s):Ross Naylor, MD, FRCS  
  View Abstract      
3:59 PM - 4:04 PM DEBATE: Early CAS After Symptom Onset Is Safe In Younger Patients Under Certain Conditions
  Presenter(s):Klaus D. Mathias, MD  
  View Abstract      
4:05 PM - 4:12 PM Panel Discussion
END OF SESSION 6
 
SESSION 7 SCHEDULE
Tuesday
SESSION 7: MORE ON THORACIC AND THORACOABDOMINAL ANEURYSMS (TAAAs); PREVENTING SPINAL CORD ISCHEMIA (SCI)
x
4:12 PM - 4:17 PM Paraplegia Following Fenestrated And Branched Aortic Endografts (F/B EVAR): Incidence, Severity And Ways To Prevent
  Presenter(s):Richard G. McWilliams, FRCR, EBIR  
  View Abstract      
4:18 PM - 4:23 PM Incidence And Treatment Of SCI After TEVAR: Role Of Pressure Controlled Automatic Spinal Fluid Drainage (Liquo Guard System)
  Presenter(s):Germano Melissano, MD  
  View Abstract      
4:24 PM - 4:29 PM Value Of Neuromonitoring During Open And Endo TAAA Repairs: How To Do It
  Presenter(s):Michael J. Jacobs, MD  
  View Abstract      
4:30 PM - 4:35 PM Vascular Specialists Doing TEVAR May Be Underestimating The Paraplegia Risk: Pearls To Keep In Mind From A Senior TAAA Surgeon
  Presenter(s):Charles W. Acher, MD  
  View Abstract      
4:36 PM - 4:41 PM Incidence, Clinical Features Of SCI Associated With Endovascular Repair Of TAAAs: How To Treat And Prevent This Complication
  Presenter(s):Matthew J. Eagleton, MD  
  View Abstract      
4:42 PM - 4:47 PM Best Approaches To Preventing SCI During TEVAR And Open Repair Of TAAAs: Pearls Regarding Etiology, Monitoring And Treating
  Presenter(s):Hamdy Awad, MD / Patrick Vaccaro, MD  
  View Abstract      
4:48 PM - 4:53 PM Panel Discussion
END OF SESSION 7
 
SESSION 8 SCHEDULE
Tuesday
SESSION 8: MORE ON THORACIC AORTIC DISEASE, TEVAR AND TBADs
x
4:54 PM - 4:59 PM Ascending Aortic Complications Following TEVAR: How Can They Be Diagnosed And Treated Successfully
  Presenter(s):Roberto Chiesa, MD  
  View Abstract      
5:00 PM - 5:05 PM Periscope Endografts To Revascularize The Left Subclavian Artery (LSA) During TEVARs Covering Its Origin: Technique And Advantages
  Presenter(s):Mario Lachat, MD  
  View Abstract      
5:06 PM - 5:11 PM Can PET-CT Help To Indicate Which Uncomplicated TBAD Will Become Complicated: Should This Be An Indication For TEVAR
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Abstract      
5:12 PM - 5:17 PM How To Manage Complications Of Malperfusion After Coverage Of The TBAD Primary Tear By TEVAR: Tips And Tricks
  Presenter(s):Ali Azizzadeh, MD / Mohammad H. Eslami, MD, RVT / Hazim J. Safi, MD  
  View Abstract      
5:18 PM - 5:23 PM Why The INSTEAD Trials Are Not Enough To Justify TEVAR For All Uncomplicated TBADs And Why We Need Additional Trials
  Presenter(s):Firas F. Mussa, MD  
  View Abstract      
5:24 PM - 5:29 PM Evaluation Of Dynamic Intimal Flap Movement In TBAD Patients: Effect Of TEVAR And How Important Is Time After Onset In Determining Flap Mobility
  Presenter(s):Frank R. Arko, MD  
  View Abstract      
5:30 PM - 5:35 PM Adjunctive False Lumen Techniques For Endovascular Repair Of Chronic TBADs: When Are They Needed
  Presenter(s):Eric E. Roselli, MD  
  View Abstract      
5:36 PM - 5:41 PM Relationship Between Aortic Morphology After TEVAR And Clinical Outcomes With TBADs
  Presenter(s):Matt M. Thompson, MD  
  View Abstract      
5:41 PM - 5:46 PM Tricks And Pitfalls For Antegrade Endograft Delivery During Open Repair Of Acute Type A Aortic Dissections
  Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD  
  View Abstract      
5:47 PM - 5:55 PM Panel Discussion

End of Program A

END OF SESSION 8
 
SESSION 9 SCHEDULE
Tuesday
SESSION 9: LOWER EXTREMITY OCCLUSIVE DISEASE MANAGEMENT HOT TOPICS – NEW TECHNIQUES AND NEW DEVICES
x
6:48 AM - 6:53 AM Ultrasound Guidance To Decrease Access Site Complications: An Essential Tool Even For Experienced Interventionalists
  Presenter(s):Peter A. Schneider, MD  
  View Abstract      
6:54 AM - 6:59 AM Role Of Directional Atherectomy For Treatment Of Lower Extremity Occlusive Disease: Is There A Gender Effect
  Presenter(s):Lawrence A. Garcia, MD  
  View Abstract      
7:00 AM - 7:05 AM Advantages And Limitations Of The Tack-It Device System For Minimizing Dissection After Plain Old Balloon Angioplasty (POBA) And Leaving Minimal Metal Behind: The TOBA Study
  Presenter(s):Marianne Brodmann, MD  
  View Abstract      
7:06 AM - 7:11 AM Technical Tips And Tricks To Optimize The Performance And Outcomes With The Supera Stent And Probably All Stents: Proper Sizing, Avoiding Elongation And Adequate Predilitation Matter In Producing Good 3-Year Results
  Presenter(s):D. Christopher Metzger, MD   
  View Abstract      
7:12 AM - 7:17 AM How To Use Drug Eluting Stents (DES) In Infrapopliteal Bifurcations
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Abstract      
7:18 AM - 7:23 AM Use Of Collaterals For Access And Retrograde Wire Passage: How To Do It
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Abstract      
7:24 AM - 7:29 AM When And How To Treat Below The Ankle Occlusive Disease: What Percent Of CLI Patients Will Require It
  Presenter(s):Roberto Ferraresi, MD  
  View Abstract      
7:30 AM - 7:35 AM With Below Knee (BK) Chronic Total Occlusions (CTOs), Success Depends On Choosing The Right Tools And Techniques: What New Tools And Techniques Exist To Help With Pedal And Tibial Access Like 3 French Sheaths And Systems
  Presenter(s):Andrej Schmidt, MD  
  View Abstract      
7:36 AM - 7:42 AM Panel Discussion
END OF SESSION 9
 
SESSION 10 SCHEDULE
Tuesday
SESSION 10: LOWER EXTREMITY HOT TOPICS – MORE NEW TECHNOLOGIES AND THE IMPORTANCE OF TECHNIQUE; DEBATES
x
7:42 AM - 7:47 AM DEBATE: For CLI: Endovascular Treatments Should Be Used First In 100% Of Patients
  Presenter(s):Marc Bosiers, MD / Koen Deloose, MD  
  View Abstract      
7:48 AM - 7:53 AM DEBATE: For CLI: Open Surgery Should Be Used First In Some Patients: Which Ones
  Presenter(s):Firas F. Mussa, MD  
  View Abstract      
7:54 AM - 7:59 AM Value Of Ultrasound Guided Pedal Access To Treat CLI: How Can It Facilitate Use Of The Diamond Back Atherectomy Device: How Best To Close The Puncture Site
  Presenter(s):Jihad A. Mustapha, MD  
  View Abstract      
8:00 AM - 8:05 AM How Do Stent Characteristics/Details And Technical Details Of PTA Balloon Usage Affect Outcomes And Incidence Of Restenosis: Oversizing Matters And Is Bad
  Presenter(s):Dierk Scheinert, MD  
  View Abstract      
8:06 AM - 8:11 AM How To Optimize Outcomes With SFA Interventions: Details Of Stent Design And Deployment Techniques Are Important In Determining Restenosis And Failure As Is Predilatation With An Uncoated Balloon Before DEBs
  Presenter(s):Stefan Mueller-Hülsbeck, MD  
  View Abstract      
8:12 AM - 8:17 AM DEBATE: Why In Treating BK CTOs It Is Best To Stay Intraluminal
  Presenter(s):Marco G. Manzi, MD  
  View Abstract      
8:18 AM - 8:23 AM DEBATE: Subintimal Angioplasty Is Very Useful And Often Unavoidable In Treating BK CTOs
  Presenter(s):Amman Bolia, MD  
  View Abstract      
8:24 AM - 8:29 AM 15-Year Trends In CLI Treatment And Major Amputation: Better Care Is Making A Difference: Is It Due To Better Interventional And Bypass Treatment: Does Increased CLI Spending Increase Limb Salvage And Decrease Amputation Rates
  Presenter(s):Philip P. Goodney, MD, MS  
  View Abstract      
8:30 AM - 8:37 AM Panel Discussion
END OF SESSION 10
 
SESSION 11 SCHEDULE
Tuesday
SESSION 11: MORE LOWER EXTREMITY HOT TOPICS – NEW STENT AND DRUG ELUTING BALLOON (DEB) DATA; IMPACT AND COST ISSUES
x
8:38 AM - 8:43 AM Is There A Negative Effect Of Endovascular Failure On Bypass Outcomes: Is It Reality Or A Myth
  Presenter(s):Michael S. Conte, MD  
  View Abstract      
8:44 AM - 8:49 AM What Is The Effect Of Extensive Lesion Calcification On The Outcome Of DEB Treatment
  Presenter(s):Gunnar Tepe, MD  
  View Abstract      
8:50 AM - 8:55 AM Why Are DEBs Cost Effective For Treating CLI Patients
  Presenter(s):Thomas Zeller, MD  
  View Abstract      
8:56 AM - 9:01 AM How To Align Financial Incentives For The Doctor, The Hospital And The Payer (Insurance Company) To Provide The Best And Most Effective Care In The Least Costly Manner: Impact Of Expensive New Technologies And Reintervention Rates
  Presenter(s):W. Charles Sternbergh III, MD  
  View Abstract      
9:02 AM - 9:07 AM Tips And Tricks For Tibial Interventions For CLI
  Presenter(s):Roberto Ferraresi, MD  
  View Abstract      
9:08 AM - 9:13 AM What’s New With US Approved Drug Eluting Stents (DESs) In The SFA And Below
  Presenter(s):Ron Waksman, MD  
  View Abstract      
9:14 AM - 9:19 AM 5-Year Results And New Findings From The Zilver PTX RCT And Registry: Benefits Of DESs Are Durable And Value With In Stent Restenosis (ISR), Long Lesions And Diabetics
  Presenter(s):Michael D. Dake, MD  
  View Abstract      
9:20 AM - 9:25 AM 2-3-Year Results With EverFlex Helical Nitinol Stent In The SFA And The Popliteal Artery: Are The Benefits Durable
  Presenter(s):Marc Bosiers, MD / Patrick Peeters, MD  
  View Abstract      
9:25 AM - 9:33 AM Panel Discussion
9:33 AM - 9:48 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 11
 
SESSION 12 SCHEDULE
Tuesday
SESSION 12: IN HONOR OF ROBERT B. RUTHERFORD, MD: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA; CLI, STENTS AND DEBs
x
FOR SFA AND POPLITEAL LESIONS
9:48 AM - 9:53 AM Update On The Efficacy Of DEBs For SFA And Popliteal Artery Lesions: Why Some Trials Are Positive And Some Negative: Are Good Results Holding Up: GLOBAL IN.PACT Registry Results In >1400 Patients
  Presenter(s):Gunnar Tepe, MD / Dierk Scheinert, MD  
  View Abstract      
9:54 AM - 9:59 AM POBA And “Vanella” Bare Metal Stents (BMS) Have Merit In Some AK And BK Occlusive Lesions Reserving The Fancy And Costly Stuff For Special Situations
  Presenter(s):Iris Baumgartner, MD  
  View Abstract      
10:00 AM - 10:05 AM What Have We In The US Learned From Our European Colleagues About CLI Treatment That Can Be Used To Improve Patient Care In The US
  Presenter(s):Craig M. Walker, MD  
  View Abstract      
10:06 AM - 10:11 AM Stenting For Femoral And Popliteal Artery Lesions: Where Do We Currently Stand And What Problems Remain
  Presenter(s):Erich Minar, MD  
  View Abstract      
10:12 AM - 10:17 AM Role Of DEBs vs. DESs For SFA Lesions And Value Of Paclitaxel DEBs For Long SFA Lesions: Is There Level 1 Proof Of Benefit
  Presenter(s):Thomas Zeller, MD  
  View Abstract      
10:18 AM - 10:23 AM Paclitaxel Coated DEBs Are Better Than Uncoated Balloons In The SFA: 1-Year Results From The IN.PACT SFA I/II RCTs
  Presenter(s):Peter A. Schneider, MD / John R. Laird, MD / Gunnar Tepe, MD  
  View Abstract      
10:24 AM - 10:29 AM DEBs Are Effective For SFA Lesions: 1-Year Results From The LEVANT II RCT Show It To Be So With The Bard Lutonix DEB: Stents Were Rarely Needed
  Presenter(s):Kenneth Rosenfield, MD / Dierk Scheinert, MD  
  View Abstract      
10:30 AM - 10:35 AM Durability Of Paclitaxel Coated DEBs In The SFA: Long-Term (3-Year) Results Of The PACIFIER Trial
  Presenter(s):Michael Werk, MD  
  View Abstract      
10:36 AM - 10:41 AM Mid-Term Results From The Belgian IN.PACT Trial Of Paclitaxel Coated DEBs vs. POBA: What Is Special About This Trial
  Presenter(s):Erik E. Debing, MD, PhD  
  View Abstract      
10:42 AM - 10:50 AM Panel Discussion
FOR BK AND INFRAPOPLITEAL LESIONS
Moderator(s): Michael S. Conte, MD / George H. Meier III, MD  
10:50 AM - 10:55 AM How Often After Tibial Interventions For CLI Are Reinterventions Required: We Need Better Primary Treatments: What Are The Cost Implications
  Presenter(s):Nicolas A. Diehm, MD / Iris Baumgartner, MD  
  View Abstract      
10:56 AM - 11:01 AM Single Center RCT Of IN.PACT Deep Paclitaxel Coated DEBs vs. Uncoated Balloons Shows Benefit For BK Lesions Causing CLI: 3-Year Results Of The DEBATE Trial
  Presenter(s):Francesco Liistro, MD  
  View Abstract      
11:02 AM - 11:07 AM Single Center Results With Paclitaxel Coated DEBs For Infrapopliteal Lesions Shows Benefits: What Are They
  Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD  
  View Abstract      
11:08 AM - 11:13 AM A Multicenter RCT (IN.PACT DEEP) Comparing Paclitaxel Coated DEBs With Uncoated Balloons Fails To Show Benefit For The DEBs
  Presenter(s):Thomas Zeller, MD  
  View Abstract      
11:14 AM - 11:19 AM Why Do The SINGLE CENTER Trial And Other BK DEB Results Differ From The Multicenter Trial Results: All DEBs Are Not Equal Or Used Equally: A Critical Analysis Of All Data And Some 3-Year Results
  Presenter(s):Francesco Liistro, MD  
  View Abstract      
11:20 AM - 11:25 AM How To Explain Differing Results Of RCTs Of DEBs In BK And Infrapopliteal Lesions: When Will We Get DEBs For BK Lesions In The US
  Presenter(s):Krishna J. Rocha-Singh, MD  
  View Abstract      
11:26 AM - 11:31 AM DEBs: Are They A Breakthrough Technology Or Another Tool In The Box: Why Is There Still Uncertainty: Do The PACUBA Trial Results With SFA/POP In Stent Restenosis (ISR) Help
  Presenter(s):Johannes Lammer, MD  
  View Abstract      
11:32 AM - 11:37 AM How Long Is Restored Patency Needed In CLI Patients; What Leads To Increased Limb Salvage With Poor Patency: Importance Of Reintervention, DESs And DEBs
  Presenter(s):Frank E.G. Vermassen, MD, PhD  
  View Abstract      
11:38 AM - 11:43 AM How Important To Interventional Outcomes Is Leaving No Foreign Body Or Metal Behind In The Artery: How Can It Be Achieved
  Presenter(s):Giancarlo Biamino, MD, PhD / Dierk Scheinert, MD  
  View Abstract      
11:44 AM - 11:49 AM Variable And High Total Costs For Caring For CLI Patients: What Can Be Done To Cut Costs Without Impairing Patient Care
  Presenter(s):Timothy M. Sullivan, MD  
  View Abstract      
11:50 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 12
 
SESSION 13 SCHEDULE
Tuesday
SESSION 13: IN HONOR OF JOHN J. BERGAN, MD: MORE LOWER EXTREMITY ISCHEMIA TREATMENT – ROLE OF OPEN SURGERY; IN STENT RESTENOSIS (ISR) MANAGEMENT – DEBs, DESs, ATHERECTOMY
x
ROLE OF OPEN SURGERY
1:00 PM - 1:05 PM Extreme Distal Vein Bypasses After Failed Endovascular Treatments
  Presenter(s):Giustino Marcucci, MD  
  View Abstract      
1:06 PM - 1:11 PM Pedal Bypass With Deep Venous Arterialization: Long-Term Results And Hemodynamic Changes Are Surprisingly Good: Is It An Option After Failed Arterial Bypasses And Endovascular Treatments
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
  View Abstract      
1:12 PM - 1:17 PM Endovascular vs. Open Treatments For Lower And Upper Extremity CLI: How To Avoid Failure And Bad Outcomes
  Presenter(s):Francesco Spinelli, MD  
  View Abstract      
1:18 PM - 1:23 PM DEBATE: Endovascular Treatment First In All Patients With CLI Is Best
  Presenter(s):Craig M. Walker, MD  
  View Abstract      
1:24 PM - 1:29 PM DEBATE: Open Surgical Treatment First Is Best For Some CLI Patients: Which Ones And Why
  Presenter(s):Michael S. Conte, MD  
  View Abstract      
1:30 PM - 1:35 PM What Is The Best Treatment Strategy For CLI Patients In Terms Of Outcomes And Cost: When Open First, When Endo First
  Presenter(s):Timothy M. Sullivan, MD  
  View Abstract      
1:36 PM - 1:42 PM Panel Discussion
DEBS AND TREATMENT OF ISR
Moderator(s): Giancarlo Biamino, MD, PhD / Michael B. Silva, Jr., MD  
1:43 PM - 1:48 PM Importance Of Technique In Avoiding Dissection With PTA Using DEBs And Standard Balloons: Does Good Flow Matter: How To Know: When Are Stents Really Necessary
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
  View Abstract      
1:49 PM - 1:54 PM How To Cross And Recanalize Chronically Occluded Stents: Stent Puncture And The Radiofrequency PowerWire Can Be Helpful: Technical Tips
  Presenter(s):Marcelo Guimaraes, MD  
  View Abstract      
1:55 PM - 2:00 PM Treatment Of ISR: DEBs Are OK If The Lesion Is Just Intimal Hyperplasia: A Stent Is Required If The Lesion Is Severely Calcified
  Presenter(s):Dierk Scheinert, MD  
  View Abstract      
2:01 PM - 2:06 PM DEBATE: Laser Atherectomy And Stent Graft vs. Laser Atherectomy And DEB For ISR: Which Is Best And Why Debulking Is Essential
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Abstract      
2:07 PM - 2:12 PM DEBATE: For ISR, POBA vs. DEB vs. DES vs. Covered Stent: 1-Year Results Of The FAIR Trial With The IN.PACT Admiral DEB: Debulking Is Not Necessary
  Presenter(s):Hans Krankenberg, MD  
  View Abstract      
2:13 PM - 2:18 PM The Ocelot OCT Catheter For Crossing CTOs And The Next Generation Atherectomy Device (Phoenix): How Are They Better And In Which Arteries
  Presenter(s):James F. McKinsey, MD  
  View Abstract      
2:19 PM - 2:24 PM How Well Do Paclitaxel Coated DEBs Work For ISR In CLI Patients With Diabetes: 3-Year Results From The DEBATE RCT
  Presenter(s):Francesco Liistro, MD  
  View Abstract      
2:25 PM - 2:30 PM In Memoriam And Recognition Of 5 Giants In Vascular Surgery Who Are No Longer With Us: John Bergan, James DeWeese, Roy Greenberg, Robert Rutherford And David Sumner
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
  View Abstract      
2:31 PM - 2:38 PM Panel Discussion
END OF SESSION 13
 
SESSION 14 SCHEDULE
Tuesday
SESSION 14: NEW DEVELOPMENTS WITH STENT-GRAFTS FOR OCCLUSIVE DISEASE AND ISR
Moderators:Gary Giangola, MD  
x
2:38 PM - 2:43 PM Use Of Stent-Grafts To Avoid Rupture And Embolization In Endovascular Treatment Of Complex Iliac Artery Occlusive Disease
  Presenter(s):Maria Antonella Ruffino, MD  
  View Abstract      
2:44 PM - 2:49 PM DEBATE: For Long SFA Occlusions DEBs Or Viabahn Propaten Stent-Grafts Are The Best Treatment With The Best Outcomes: Will Drug Coating Tips To Stent-Grafts Improve Results: Will They Be Available
  Presenter(s):Thomas Zeller, MD  
  View Abstract      
2:50 PM - 2:55 PM DEBATE: For Long SFA Occlusions Zilver PTX DESs Are The Best Treatment With The Best Results
  Presenter(s):Michael D. Dake, MD  
  View Abstract      
2:56 PM - 3:01 PM Technical Considerations For Optimal Use Of Viabahn Covered Stents For Long SFA Occlusive Lesions: Lessons Learned From The VIPER And VIASTAR Trials
  Presenter(s):Dennis R. Gable, MD, FACS  
  View Abstract      
3:02 PM - 3:07 PM 2-Year Results Of The RELINE Trial Comparing Viabahn Stent-Grafts To POBA For ISR Show Durable Benefits To Endograft Treatment
  Presenter(s):Marc Bosiers, MD / Koen Deloose, MD  
  View Abstract      
3:08 PM - 3:13 PM Interim Analysis Of The SUPER B Trial Comparing Heparin Bonded Viabahn Endografts To Vein Bypasses For SFA Occlusive Disease
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Abstract      
3:14 PM - 3:19 PM Covered Balloon Expandable Endovascular Graft Reconstruction Of The Aortic Bifurcation (CERAB Procedure) For Aorto-Iliac Occlusive Disease: 2-Year Results And Hemodynamic And Other Advantages
  Presenter(s):Peter C.J. Goverde, MD  
  View Abstract      
3:20 PM - 3:26 PM Panel Discussion
3:26 PM - 3:38 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 14
 
SESSION 15 SCHEDULE
Tuesday
SESSION 15: NEW DEVELOPMENTS IN THE TREATMENT OF ACUTE LOWER EXTREMITY ISCHEMIA (ALI) AND INTERMITTENT CLAUDICATION
x
ACUTE LOWER EXTREMITY ISCHEMIA
3:38 PM - 3:43 PM How To Avoid Groin Incisions In Hostile Groins When Performing Femoral Embolectomy
  Presenter(s):Rajiv Parakh, MBBS, MS, FRCS  
  View Abstract      
3:44 PM - 3:49 PM Percutaneous Endovascular Thrombosuction: Devices, Techniques, Indications And Results
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
  View Abstract      
3:50 PM - 3:55 PM Advantages To Indigo Mechanical Thrombectomy For ALI: Device And Technique
  Presenter(s):Claudio J. Schonholz, MD  
  View Abstract      
3:56 PM - 4:01 PM DEBATE: Endovascular Treatments Can Treat Almost All Patients With ALI
  Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD  
  View Abstract      
4:02 PM - 4:07 PM DEBATE: Some Patients With ALI Require Open Surgical Treatment – Either A Bypass Or Open Thrombectomy: Which Patients
  Presenter(s):Joseph L. Mills, MD  
  View Abstract      
4:08 PM - 4:13 PM Young Athletes With ALI Should Have An Endovascular First Approach: What Are The Causes Of The ALI
  Presenter(s):Werner Lang, MD  
  View Abstract      
4:14 PM - 4:19 PM Cancer And ALI: A Deadly Combination: Why
  Presenter(s):Cynthia K. Shortell, MD  
  View Abstract      
4:20 PM - 4:25 PM With ALI: When Endo; When Open: What Are The Mid-Term Outcomes
  Presenter(s):Rabih A. Chaer, MD  
  View Abstract      
NEW DATA REGARDING INTERMITTENT CLAUDICATION AND ITS TREATMENT
4:26 PM - 4:31 PM Current Drug And Non-Interventional Treatments For Intermittent Claudication: Are They Effective
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Abstract      
4:32 PM - 4:37 PM For Intermittent Claudication: Immediate Treatment vs. Delayed Treatment vs. No Treatment: Which Is Best
  Presenter(s):Gregory L. Moneta, MD  
  View Abstract      
4:38 PM - 4:43 PM Endovascular vs. Exercise Treatment For Intermittent Claudication: Which Is Best
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
  View Abstract      
4:44 PM - 4:50 PM Panel Discussion
END OF SESSION 15
 
SESSION 16 SCHEDULE
Tuesday
SESSION 16: NEW DEVELOPMENTS IN CHRONIC CLI AND ITS TREATMENTS: THE ANGIOSOME CONCEPT – PROS AND CONS
x
4:50 PM - 4:55 PM Advantages Of New SVS Lower Extremity Threatened Limb Classification System For Risk Stratification Based On Wound, Ischemia And Foot Infection
  Presenter(s):Joseph L. Mills, MD / Michael S. Conte, MD  
  View Abstract      
4:56 PM - 5:01 PM Advantages Of And Indications For The Supera Stent – A Vascular Mimetic Implant With Special Properties: High Radial Strength, Low Chronic Outward Force: Tips And Tricks For Implanting And Using
  Presenter(s):Peter C.J. Goverde, MD  
  View Abstract      
5:02 PM - 5:07 PM 3-Year Results With The Supera Interwoven Biomimetic Stent For Femoro-Popliteal Lesions Based On The SUPER B Trial: Why Is This Stent Better Than Others
  Presenter(s):Lawrence A. Garcia, MD / Kenneth Rosenfield, MD / Dierk Scheinert, MD  
  View Abstract      
5:08 PM - 5:13 PM How To Measure Success And Failure With Interventional Treatments For Lower Extremity Ischemia: The Difference Between Thrombosis And Occlusion
  Presenter(s):Kenneth Ouriel, MD, MBA  
  View Abstract      
5:14 PM - 5:19 PM Lower Extremity Outcomes With Fancy Endovascular Devices: We Should Remain Skeptical And Look At The Data
  Presenter(s):Scott L. Stevens, MD  
  View Abstract      
5:20 PM - 5:25 PM Is Directional Atherectomy (Silverhawk Or Turbohawk) With DEB, Better Than DEB Alone: Based On The DEFINITIVE AR RCT: 1-Year Results
  Presenter(s):Gunnar Tepe, MD / Thomas Zeller, MD  
  View Abstract      
PROS AND CONS OF THE ANGIOSOME CONCEPT
5:26 PM - 5:31 PM DEBATE: The Angiosome Concept Is Necessary And Critical In Diabetic/CLI Patients
  Presenter(s):Richard F. Neville, MD / Anton N. Sidawy, MD, MPH  
  View Abstract      
5:32 PM - 5:37 PM DEBATE: The Angiosome Concept Need Not Be Followed In Diabetic Patients With CLI
  Presenter(s):Ignacio Escotto, MD  
  View Abstract      
5:38 PM - 5:43 PM Is The Angiosome Concept Real In Determining Limb Salvage: Results Of A 2-Center Study
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
  View Abstract      
5:44 PM - 5:49 PM Perfusion Measurements Before And After Tibial PTA Do Not Support The Angiosome Concept
  Presenter(s):Werner Lang, MD  
  View Abstract      
5:50 PM - 5:55 PM Assessing Pedal Microcirculation With An Angiographic Wound Blush: Successful Revascularization And Wound Healing Can Occur Beyond Angiosomes And Beyond Pedal Loop Patency: Angiosomes Differ In Various Patients And Are Not The Holy Grail
  Presenter(s):John H. Rundback, MD, FSIR, FAHA  
  View Abstract      
5:56 PM - 6:01 PM There Is Still A Role For Primary Major Amputation For CLI: When Is It Indicated
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
  View Abstract      
6:02 PM - 6:10 PM Panel Discussion

End of Program B

END OF SESSION 16
 
SESSION 17 SCHEDULE
Tuesday
SESSION 17: NATURAL HISTORY, BEST MEDICAL TREATMENT, PREVENTION OF ARTERIOSCLEROSIS AND ITS COMPLICATIONS
x
6:43 AM - 6:48 AM Can Medical Treatment Slow The Growth Of Small AAAs
  Presenter(s):Frank A. Lederle, MD  
  View Abstract      
6:49 AM - 6:54 AM Are There New Medical Techniques For Limiting AAA Growth With Drugs (Telmisartan) And Cell Therapy: How Can They Work
  Presenter(s):Ronald L. Dalman, MD  
  View Abstract      
6:55 AM - 7:00 AM Are Statins Decreasing The AAA Rupture Rate: Results From A Danish Nationwide Population-Based Study
  Presenter(s):Jes S. Lindholt, MD  
  View Abstract      
7:01 AM - 7:06 AM A New Agent PCSK9 To Lower LDL: How Low Can LDL Go And Is It Safe
  Presenter(s):Ron Waksman, MD  
  View Abstract      
7:07 AM - 7:12 AM What Is The Association Between The A/B Index And MI And Stroke Risk: Can It Be Altered; What Is The Association Between Obesity And Vascular Disease In Various Vascular Beds: When Is Being Fat Good
  Presenter(s):Caron B. Rockman, MD  
  View Abstract      
7:13 AM - 7:18 AM DEBATE: Statins Have No Role To Play In Primary Prevention And Should Be Avoided In Most Patients
  Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC  
  View Abstract      
7:19 AM - 7:24 AM DEBATE: Nonsense: Statins Are A Game Changer, A Miracle Drug: They Should Be Used More Widely In Primary Prevention: Optimal Dosage Of Which Drug
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Abstract      
7:25 AM - 7:30 AM Statins In Vascular Patients: Are There Non-Responders And Responders – How To Tell And What To Do With Non-Responders: What To Do When Patients Have “Apparent Toxicity”: How To Load Preop And Preprocedurally
  Presenter(s):Don Poldermans, MD  
  View Abstract      
7:31 AM - 7:36 AM Optimal Beta Blocker Management In Patients Requiring Vascular Surgery Or Intervention: Current Facts And Optimal Dosing And Drug
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
  View Abstract      
7:35 AM - 7:45 AM Panel Discussion
END OF SESSION 17
 
SESSION 18 SCHEDULE
Tuesday
SESSION 18: INTERVENTIONAL TREATMENT OF HYPERTENSION AND OTHER MEDICAL DISEASES – RENAL DENERVATION
x
7:45 AM - 7:50 AM Role Of Sympathetic Nervous System In Cardiovascular Function And Hypertension: How Does Renal Artery Denervation Produce A Drop In Blood Pressure
  Presenter(s):John W. Osborn, PhD  
  View Abstract      
7:51 AM - 7:56 AM Renal Denervation For Drug Resistant Hypertension: Does It Work: Many Trials Say It Does And Yet SIMPLICITY III Says It Does Not: Does The Emperor Have No Clothes
  Presenter(s):Ron Waksman, MD  
  View Abstract      
7:57 AM - 8:02 AM Collateral Benefits Of Renal Denervation: Reasons Why SIMPLICITY III Did Not Meet Its Goals: Will Other Techniques To Decrease Sympathetic Tone And Blood Pressure Work: How About Barostimulation (Rheos Device) And A-V Fistula (With ROX Device)
  Presenter(s):Krishna J. Rocha-Singh, MD  
  View Abstract      
8:03 AM - 8:08 AM Unanswered Questions About Renal Denervation After SIMPLICITY III; What Other Devices Are Being Evaluated And Will They Be Effective (Northwind, Paradise, Ultrasound, Etc.)
  Presenter(s):Horst Sievert, MD  
  View Abstract      
8:09 AM - 8:14 AM Where Do We Go After SIMPLICITY III: Is There Evidence That Renal Denervation Will Work: Are There Other Devices And Technology And What Do They Offer
  Presenter(s):Yvonne Bausback, MD / Dierk Scheinert, MD  
  View Abstract      
8:15 AM - 8:20 AM What Is Required To Support A Renal Denervation Practice For Resistant Hypertension And Other Devices: Should Vascular Surgeons Consider Setting Up Such A Program Before Everyone Else Jumps On The Bandwagon
  Presenter(s):Christoph A. Nienaber, MD, PhD  
  View Abstract      
8:21 AM - 8:26 AM Defining Real Resistant Hypertension: Are There Responders And Non-Responders To Renal Denervation And Can RF (Radiofrequency) Treatment Injure The Renal Arteries
  Presenter(s):Melvin D. Lobo, MBChB, PhD, FRCP  
  View Abstract      
8:27 AM - 8:32 AM Failure Of SIMPLICITY III To Demonstrate Efficacy Of Renal Denervation By Endovascular RF Could Be Due To Nerve Distribution Far From The Renal Artery Lumen: Is Surgical Perirenal Neurolysis Possible And What Is Its Effect
  Presenter(s):Juan C. Parodi, MD  
  View Abstract      
8:33 AM - 8:39 AM Panel Discussion
END OF SESSION 18
 
SESSION 19 SCHEDULE
Tuesday
SESSION 19: TREATMENT AND AVOIDANCE OF COMPLICATIONS; ENDOLEAKS AND THEIR MANAGEMENT
x
MANAGEMENT OF COMPLICATIONS
8:39 AM - 8:44 AM Access Site Complications After Non-Cardiac Interventions: Incidence, Predictive Factors, How To Prevent And Outcomes: Value Of Routine Ultrasound Guidance
  Presenter(s):Mark W. Mewissen, MD  
  View Abstract      
8:45 AM - 8:50 AM Endovascular Treatment Of Anastomotic Complications After Open Surgery – Including False Aneurysms And Infections
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Abstract      
8:51 AM - 8:56 AM Endovascular Treatment Of Tracheo-Innominate Artery Fistulas: How To Do It Successfully
  Presenter(s):Gabriel Szendro, MD  
  View Abstract      
8:57 AM - 9:02 AM Successful Treatment Of An Innominate Artery-Tracheal Fistula With A Modified Endograft
  Presenter(s):Evan C. Lipsitz, MD  
  View Abstract      
NEW DEVELOPMENTS IN ENDOLEAK MANAGEMENT
9:03 AM - 9:08 AM What Is Currently The Best Information About The Significance Of TypeType 2 Endoleaks: How Are They Best Diagnosed And Treated
  Presenter(s):Kim J. Hodgson, MD  
  View Abstract      
9:09 AM - 9:14 AM Conservative (Observational) Management Is Appropriate For Some Primary Type 1A Endoleaks After EVAR And TEVAR Procedures: Which Ones
  Presenter(s):Frans L. Moll, MD, PhD  
  View Abstract      
9:15 AM - 9:20 AM What Are The Real Causes Of Endotension: Can A Hypervascular AAA Sac Wall Cause It: How To Diagnose And Treat It
  Presenter(s):Timur P. Sarac, MD  
  View Abstract      
9:21 AM - 9:26 AM Type 1 Endoleaks After EVAR: Role Of Onyx In Fixing Them: Tips And Tricks For Its Use And How To Diagnose And Treat Those That Masquerade As Type 2 Endoleaks
  Presenter(s):Robert A. Morgan, MD  
  View Abstract      
9:27 AM - 9:32 AM What Is The Real Long-Term Outcome Of Type 2 Endoleaks: Based On A Single Center And The OVER Trial Experience
  Presenter(s):Wei Zhou, MD  
  View Abstract      
9:33 AM - 9:38 AM Open Aortic Wrap For Persistent Type 1A Endoleak: Technical Tips And Results
  Presenter(s):Ross Milner, MD  
  View Abstract      
9:39 AM - 9:44 AM Accurate Endoleak Detection And Characterization Using Temporal Information From Contrast Enhanced Ultrasound
  Presenter(s):S. Rao Vallabhaneni, MD, FRCS  
  View Abstract      
9:45 AM - 9:52 AM Panel Discussion
9:52 AM - 10:05 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 19
 
SESSION 20 SCHEDULE
Tuesday
SESSION 20: OPTIMAL PERIPROCEDURAL MEDICAL MANAGEMENT IN VASCULAR PATIENTS; SOME INTERESTING HISTORY AND TECHNOLOGY; THE CCSVI FOR MULTIPLE SCLEROSIS (MS) CONTROVERSY
x
PERIPROCEDURAL MANAGEMENT, INTERESTING HISTORY AND TECHNOLOGY
10:05 AM - 10:10 AM Periop And Periprocedural Care Is Key For Vascular Patients: What Is Optimal Antiplatelet Treatment; Statin Dosage, Drugs And Loading; And Beta Blockade
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Abstract      
10:11 AM - 10:16 AM Scandalous High Long-Term Mortality After EVAR: It Is Due To MD Ignorance Regarding Statins And Other Medical Treatment: The AAA Is Fixed But MIs Kill: Statins Should Be In The Drinking Water
  Presenter(s):Matt M. Thompson, MD  
  View Abstract      
10:17 AM - 10:22 AM Heparin Management During Open AAA Repair: Is Heparin Necessary For Elective Or Ruptured AAA Repair
  Presenter(s):Arno M. Wiersema, MD  
  View Abstract      
10:23 AM - 10:28 AM How Do Statins Influence Long-Term Restenosis And Cardiovascular Events (Stroke And MI) After CEA And After CAS
  Presenter(s):Christos D. Liapis, MD  
  View Abstract      
10:29 AM - 10:34 AM Tales From The Crypt: 5000-Year-Old History Of Atherosclerosis (ASO): What It Tells Us About ASO Today
  Presenter(s):Christopher K. Zarins, MD  
  View Abstract      
10:35 AM - 10:40 AM What Andreas Gruntzig Said 30 Years Ago And Its Relevance Today
  Presenter(s):Sigrid Nikol, MD  
  View Abstract      
10:41 AM - 10:46 AM Shock Wave Lithoplasty For Treating Severely Calcified Occlusive Lesions: Theory And 30-Day CE Mark Study Results
  Presenter(s):Andrew Holden, MBChB  
  View Abstract      
10:47 AM - 10:53 AM Panel Discussion
THE CCSVI FOR MS CONTROVERSY
Moderator(s): Lindsay Machan, MD / Manish Mehta, MD, MPH  
10:53 AM - 10:58 AM What Is New In CCSVI For MS: The Positive Evidence Mounts: How To Select Patients: Can Brain Perfusion Be Improved: Is Open Vein Repair Ever Needed
  Presenter(s):Paolo Zamboni, MD  
  View Abstract      
10:59 AM - 11:04 AM Vein PTA Helps Selected MS Patients With CCSVI: There Is No Doubt: Stem Cell Therapy May Also Be Beneficial
  Presenter(s):Ivo Petrov, MD, PhD  
  View Abstract      
11:05 AM - 11:10 AM The Omohyoid Muscle Can Be A Cause Of Venous Compression Leading To CCSVI: Documentation And Relief By Resection
  Presenter(s):Alberto Lomeo, MD  
  View Abstract      
11:11 AM - 11:16 AM Regarding CCSVI And MS, A Skeptic’s View
  Presenter(s):J. David Spence, MD  
  View Abstract      
11:17 AM - 11:22 AM Despite Some Questions, There Is Still A Relationship Between CCSVI And MS And An Opportunity For A Positive Effect From Endovascular Treatment
  Presenter(s):Michael D. Dake, MD  
  View Abstract      
11:23 AM - 11:28 AM The Proper Technique For Venoplasty For CCSVI As A Contributory Cause Of MS: Variability In Technique May Account For Variable Results
  Presenter(s):Donald B. Reid, MD  
  View Abstract      
11:29 AM - 11:34 AM Is The CCSVI Concept In MS Valid: Results Of A Meta-analysis
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
  View Abstract      
11:35 AM - 11:40 AM The Presence Of Extracranial Venous Narrowing Is The Same In MS Patients And Normal Controls
  Presenter(s):Lindsay Machan, MD  
  View Abstract      
11:41 AM - 11:46 AM Update On The RCT Of Venous Balloon Angioplasty vs. Venography Placebo: What Does It Tell Us
  Presenter(s):L. Nelson Hopkins, MD / Robert Zivadinov, MD, PhD, FAAN  
  View Abstract      
11:47 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 20
 
SESSION 21 SCHEDULE
Tuesday
SESSION 21: ISSUES: VARIABLE VASCULAR CARE, GOVERNMENT, FDA, HEALTH CARE REFORM, ETHICS
x
1:00 PM - 1:05 PM How To Increase Public Awareness Of Vascular Disease And The Role Of The Specialty Of Vascular Surgery
  Presenter(s):Robert B. McLafferty, MD  
  View Abstract      
1:06 PM - 1:11 PM Disparity Of Vascular Care: Variations Of Index Vascular Procedures In Different Hospitals And Different Locations: Why
  Presenter(s):Mohammad H. Eslami, MD, RVT  
  View Abstract      
1:12 PM - 1:17 PM DEBATE: The Changes In The FDA Process For Cardiovascular Device Evaluation And Approval Will Increase US Access To Safe And Effective Devices – And Make It More Like Other Civilized Countries
  Presenter(s):Dorothy B. Abel, BSBME / J. Pablo Morales, MD  
  View Abstract      
1:18 PM - 1:23 PM DEBATE: Are The FDA Changes Really Going To Facilitate New Device Evaluation And Availability In The US: The Difficulty Lies With Congress, Not The FDA
  Presenter(s):Ron Waksman, MD  
  View Abstract      
1:24 PM - 1:29 PM Template For An IDE For Physician Modified Endografts
  Presenter(s):Patrick W. Kelly, MD / Rodney A. White, MD / Dorothy B. Abel, BSBME  
  View Abstract      
1:30 PM - 1:35 PM Perverse Incentives To Perform Vascular Procedures, And Pay For Performance Measurements Are Bad: How To Fix The Problems
  Presenter(s):Timothy F. Kresowik, MD  
  View Abstract      
1:36 PM - 1:41 PM Panel Discussion
IMPACT OF OBAMACARE
1:42 PM - 1:47 PM Impact Of Obamacare (ACA) On American Medicine And Our Country: I Thought It Was Bad But I Never Realized How Bad
  Presenter(s):Clifford J. Buckley, MD  
  View Abstract      
1:48 PM - 1:53 PM The Train Is Coming At You: What Will The Cost Of Obamacare Be To Vascular Patients And Vascular Surgeons
  Presenter(s):James H. Black III, MD  
  View Abstract      
1:54 PM - 1:59 PM Detrimental Effects Of The ACA And ACOs On The Work Environment Of Vascular Surgeons And Their Freedom To Provide The Best Care: Are Doctors-Unions A Legal And Inevitable Solution
  Presenter(s):Timothy M. Sullivan, MD  
  View Abstract      
2:00 PM - 2:05 PM The Impact Of The ACA On The Medical Device Industry: What Harm Or Benefit Will It Cause: How Are Things Working Out
  Presenter(s):Kem Hawkins, MBA  
  View Abstract      
2:06 PM - 2:11 PM Impact Of Obamacare On Vascular Surgery In 2014 And 2015
  Presenter(s):Robert M. Zwolak, MD, PhD  
  View Abstract      
2:12 PM - 2:17 PM Heart And Vascular Care In The Era Of Health Reform And The ACA: Where Are We Headed And How To Survive
  Presenter(s):John H. Furtek, BS, RT(r)  
  View Abstract      
2:18 PM - 2:23 PM The ACA Says It's Willing To Pay For Disease Prevention: Why That Is Not True
  Presenter(s):Clifford M. Sales, MD, MBA / Patricia Davidson, RN  
  View Abstract      
2:24 PM - 2:30 PM Panel Discussion
END OF SESSION 21
 
SESSION 22 SCHEDULE
Tuesday
SESSION 22: ISSUES RELATED TO INDEPENDENCE FOR VASCULAR SURGERY, RESIDENCY TRAINING, BUSINESS, REIMBURSEMENT, COST/BENEFIT, CONFLICT OF INTEREST (COI)
x
INDEPENDENCE AND GOVERNANCE ISSUES FOR VASCULAR SURGERY
2:30 PM - 2:35 PM What Have Been The Beneficial Effects For Patients And Vascular Surgeons Of Vascular Surgery Being Recognized As An Independent Specialty In Switzerland
  Presenter(s):Jürg Schmidli, MD  
  View Abstract      
2:36 PM - 2:41 PM How Has Independence Helped Vascular Surgery And Its Patients In Sweden
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Abstract      
2:42 PM - 2:47 PM How Has Independence For Its Governing Bodies Helped Vascular Surgery And Its Patients In The UK
  Presenter(s):George Hamilton, MD; FRCS  
  View Abstract      
2:48 PM - 2:53 PM How Has The European Vascular Surgery FEBVS Exam Contributed To Vascular Surgery’s Independence In Europe And Improved Patient Care
  Presenter(s):David McLain, FEBVS  
  View Abstract      
2:54 PM - 2:59 PM The American Board of Vascular Surgery (ABVS) And The Vascular Surgery Board of The American Board of Surgery (VSB of ABS): Is There More
  Presenter(s):James C. Stanley, MD  
  View Abstract      
RESIDENCY TRAINING IN VASCULAR SURGERY
3:00 PM - 3:05 PM Update On The Current Status Of 0+5 Vascular Surgery Residency Training
  Presenter(s):Murray L. Shames, MD / Karl A. Illig, MD  
  View Abstract      
3:06 PM - 3:11 PM The New Residency Review Committee-Surgery (RRC-S) Vascular Criteria For Training In General And Vascular Surgery: What Will The Case Requirements Be: Is It Good For Vascular Surgery
  Presenter(s):Ronald L. Dalman, MD  
  View Abstract      
BUSINESS, REIMBURSEMENT AND COST ISSUES
3:12 PM - 3:17 PM What Is Happening With Vascular Procedural Reimbursement In 2015: How Bad Will It Be
  Presenter(s):Sean P. Roddy, MD  
  View Abstract      
3:18 PM - 3:23 PM Current Business Considerations In Medicine And Reimbursement: How Can We Deal With Them
  Presenter(s):Glenn Jacobowitz, MD / Mark A. Adelman, MD  
  View Abstract      
3:24 PM - 3:29 PM What Vascular Specialists Can Do To Protect Their Assets From Frivolous Law Suits Related To Malpractice And Other Issues
  Presenter(s):Hillel Presser, Esq., MBA  
  View Abstract      
3:30 PM - 3:35 PM Heart And Vascular Institutes: Boons Or Busts For Vascular Surgeons: What Are The Dangers
  Presenter(s):Timur P. Sarac, MD  
  View Abstract      
3:36 PM - 3:41 PM The FAST Vascular Concept: A Method To Reduce Resource Utilization With EVAR And Open Repair Of AAAs
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Abstract      
3:42 PM - 3:47 PM What Are The Drivers Of Cost For Treating SFA Occlusive Disease And AAAs: How Can These Costs Be Decreased
  Presenter(s):Richard J. Powell, MD  
  View Abstract      
3:48 PM - 3:53 PM Setting Up A Functional Hybrid Room Involves More Than You Think: What Resources, Personnel And Costs Must Be Involved
  Presenter(s):Rodney A. White, MD  
  View Abstract      
3:54 PM - 4:04 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 22
 
SESSION 23 SCHEDULE
Tuesday
SESSION 23: OUTPATIENT TREATMENT, IMPROVING CARE, RCTs, REGISTRIES
x
4:04 PM - 4:09 PM Advantages Of An Outpatient Endovascular Center To An Academic Vascular Surgery Department
  Presenter(s):Mark A. Adelman, MD  
  View Abstract      
4:10 PM - 4:15 PM What Organization(s) Should Set Standards, Accredit And Regulate Outpatient Vascular And Vein Diagnostic And Treatment Centers – Toward What Goals
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Abstract      
4:16 PM - 4:21 PM The Importance Of Patient Reported Outcome Measures (PROMs) To Vascular Surgeons
  Presenter(s):Mark J.W. Koelemay, MD, PhD  
  View Abstract      
4:22 PM - 4:27 PM Relationship Between Patient Satisfaction And Favorable Surgical Outcomes
  Presenter(s):K. Craig Kent, MD  
  View Abstract      
4:28 PM - 4:33 PM Income vs. Outcomes In Vascular Patients: Low Income Is An Independent Risk Factor For Outcomes: Why
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Abstract      
4:34 PM - 4:39 PM Access To Health Care Does Not Correlate With Limb Salvage In CLI: Race And Socioeconomic Status Do
  Presenter(s):Michael C. Stoner, MD  
  View Abstract      
4:40 PM - 4:45 PM LEAN Principles And Their Application To Vascular Surgery: What Can Toyota Teach Us About Providing Better Vascular Health Care
  Presenter(s):Tej M. Singh, MD, MBA  
  View Abstract      
EVIDENCE BASED MEDICINE AND RCTS
4:46 PM - 4:51 PM Commentary On Evidence Based Medicine And RCTs In Cardiovascular Surgery And Medicine; Not All RCTs Are Holy
  Presenter(s):Peter Samek, MD, PhD  
  View Abstract      
4:52 PM - 4:56 PM RCTs Can Be Underpowered And Futile To Detect Small Effects In Many Instances: Some Examples
  Presenter(s):Charles C. Miller, PhD  
  View Abstract      
4:58 PM - 5:03 PM In The Treatment Of Asymptomatic Carotid Stenosis: How Do RCTs Relate To The Real World: What Are The Pitfalls Of RCTs
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Abstract      
IMPROVED TECHNOLOGY AND VASCULAR SPECIALISTS' PRACTICES
5:04 PM - 5:09 PM How Can Social Media Help Vascular Specialists
  Presenter(s):Ido Weinberg, MD, MSc  
  View Abstract      
5:10 PM - 5:15 PM How A Smart Phone Can Change Your Practice For The Better: How A Computer Analysis Of EKGs Can Give You Ejection Fractions And Ventricular Wall Motion And Do Away With Many Cardiac Echo Studies
  Presenter(s):Lindsay Machan, MD  
  View Abstract      
5:16 PM - 5:21 PM Update On The Status Of The SVS VQI Registry And What It Can Offer Clinically And For Research
  Presenter(s):Larry W. Kraiss, MD / Jack L. Cronenwett, MD  
  View Abstract      
5:22 PM - 5:27 PM Are There Disadvantages To VQI Initiatives: Do They Give Rise To Conflicts
  Presenter(s):Kenneth Ouriel, MD, MBA  
  View Abstract      
5:28 PM - 5:34 PM Panel Discussion
END OF SESSION 23
 
SESSION 24 SCHEDULE
Tuesday
SESSION 24: ISSUES RELATING TO SIMULATION, TRAINING AND EDUCATION
Moderators:Jason T. Lee, MD / Mario Lachat, MD  
x
SIMULATION, TRAINING AND EDUCATION
5:34 PM - 5:39 PM Advantages And Limitations Of Patient Specific Simulator Rehearsal Prior To EVAR And Other Procedures
  Presenter(s):Isabelle van Herzeele, MD, PhD  
  View Abstract      
5:40 PM - 5:45 PM Simulator Training vs. Clinical Invasive Experience: A RCT Showing Benefits Of Case Specific Simulator Training Even With Experienced Operators
  Presenter(s):Lars B. Lonn, MD, PhD  
5:46 PM - 5:51 PM New Pathways And Technology To Improve Efficiency And Resource Use In Vascular Practice
  Presenter(s):Nicholas J.W. Cheshire, MD  
  View Abstract      
5:52 PM - 5:57 PM VESAP 3: Where Is It And How Can It Help In MOC And Review For The Vascular Surgery Board Exams
  Presenter(s):John F. Eidt, MD  
  View Abstract      
5:58 PM - 6:03 PM Advances In The Education Of Vascular Surgeons In Complex Endovascular Techniques: The Boot Camp Initiative And Regional Video Conferencing
  Presenter(s):Mark G. Davies, MD / Alan B. Lumsden, MD, FACS  
  View Abstract      
6:04 PM - 6:10 PM Panel Discussion

End of Program C

END OF SESSION 24
 
SESSION 25 SCHEDULE
Wednesday
SESSION 25: EXCITING NEW TECHNOLOGY AND TECHNIQUES
x
6:45 AM - 6:50 AM 4 French Instrumentation For Lower Extremity Disease Treatment As An Outpatient: Experience In >2000 Patients Over 10 Years: How To Do It
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Abstract      
6:51 AM - 6:56 AM Role Of Endovascular Adventitial Drug Delivery To Prevent Restenosis: The Bullfrog Catheter System
  Presenter(s):Christopher D. Owens, MD  
  View Abstract      
6:57 AM - 7:02 AM A New Endovascular Balloon And A New Temporary Vascular Shunt To Help Treat Vascular Injury, Hemorrhage And Shock
  Presenter(s):Todd E. Rasmussen, MD, FACS  
  View Abstract      
7:03 AM - 7:08 AM TAVR For Pure Aortic Insufficiency: How To Make It Work And What Is Left For Surgical Valve Repair
  Presenter(s):Dietmar H. Koschyk, MD  
  View Abstract      
7:09 AM - 7:14 AM Percussion Crossing Device For Calcified CTOs: How Does It Work And Early Results Of Piculet Hammer Device
  Presenter(s):Max Amor, MD  
7:15 AM - 7:20 AM Will Drug-Eluting Fully Bioabsorbable Scaffolds Prove Advantageous In The Coronary Arteries
  Presenter(s):Gregg W. Stone, MD  
  View Abstract      
7:21 AM - 7:26 AM Some Innovative New Devices From Tim Chuter: The Inch Worm Balloon; The Shapeshifter Catheter And Microstents
  Presenter(s):Timothy A.M. Chuter, DM  
  View Abstract      
7:27 AM - 7:32 AM Panel Discussion
END OF SESSION 25
 
SESSION 26 SCHEDULE
Wednesday
SESSION 26: NEW INFORMATION ABOUT PARALLEL GRAFTS – CHIMNEYS, PERISCOPES AND SANDWICH GRAFTS (CHIMPS) FOR TAAAs
x
7:32 AM - 7:37 AM Current Role Of Chimneys And Parallel Grafts For The Treatment Of Complex Aortic Aneurysms
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Abstract      
7:38 AM - 7:43 AM Value And Limitations Of Periscope Grafts For Distal TAAAs
  Presenter(s):Jason T. Lee, MD  
  View Abstract      
7:44 AM - 7:49 AM Brazilian Registry Of Sandwich Technique Repairs For TAAAs: Mid-Term Results And How Do They Compare With Results Of Fenestrated And Branched Repairs
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Abstract      
7:50 AM - 7:55 AM The Eye Of The Tiger Technique To Eliminate Gutter Endoleaks With Parallel Grafts
  Presenter(s):David J. Minion, MD  
  View Abstract      
7:56 AM - 8:01 AM Late Outcomes Of Thoracic And Visceral Chimney Grafts: Are They Durable
  Presenter(s):Martin Malina, MD, PhD  
  View Abstract      
8:02 AM - 8:07 AM DEBATE: Mid-Term Results Of Sandwich Grafts For TAAAs Equal Those Of Branched Endografts
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Abstract      
8:08 AM - 8:13 AM DEBATE: Branched Endografts Are Better Treatment For TAAAs Than Sandwich Grafts Or Other Parallel Grafts
  Presenter(s):Stephan Haulon, MD  
  View Abstract      
8:14 AM - 8:20 AM Panel Discussion
END OF SESSION 26
 
SESSION 27 SCHEDULE
Wednesday
SESSION 27: IN HONOR OF ROY K. GREENBERG, MD: MORE ABOUT TAAAs: OPEN SURGERY, CHIMPS, FENESTRATED AND BRANCHED (F/B) ENDOGRAFTS
x
8:20 AM - 8:25 AM New Strategies For Open Treatment Of TAAAs Including Sutureless Revascularization Of Renal Arteries Using A Novel Hybrid Graft And Other Techniques
  Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD  
  View Abstract      
8:26 AM - 8:31 AM Why Do TAAAs In Young Patients With Connective Tissue Disorders Still Require Open Surgery And Are There Differences Between Degenerative And Post Dissection TAAAs That Should Influence Treatment
  Presenter(s):Michael J. Jacobs, MD / Geert Willem H. Schurink, MD, PhD  
  View Abstract      
8:32 AM - 8:37 AM DEBATE: Fenestrated And Branched F/B EVAR Is The Best And Most Durable Treatment For Pararenal And Thoracoabdominal Aneurysms
  Presenter(s):Matthew J. Eagleton, MD  
  View Abstract      
8:38 AM - 8:43 AM DEBATE: Outcomes Of Multiple Chimney And Periscope Grafts For Pararenal And Thoracoabdominal Aneurysms Are Equal To F/B Endografts And More Versatile
  Presenter(s):Mario Lachat, MD  
  View Abstract      
8:44 AM - 8:49 AM Mid-Term Outcomes And Technical Tips For Sandwich Endografts To Repair Pararenal And TAAAs: Are They Competitive With F/B Endografts
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Abstract      
8:50 AM - 8:55 AM 2-Year Experience With An Off-The-Shelf Multibranched Endograft (T-Branched Graft From Cook) For TAAAs: Advantages And Limitations
  Presenter(s):Martin J. Austermann, MD / Theodosios Bisdas, MD / Konstantinos P. Donas, MD / Giovanni Torsello, MD  
  View Abstract      
8:56 AM - 9:01 AM DEBATE: Off-The-Shelf Endografts For Complex AAAs And TAAAs: They Are Up To The Job
  Presenter(s):Timothy A. Resch, MD, PhD  
  View Abstract      
9:02 AM - 9:07 AM DEBATE: Off-The-Shelf Endografts For Complex AAAs And TAAAs: They Are Not Ready For Wide Usage
  Presenter(s):Colin D. Bicknell, MD, FRCS  
  View Abstract      
9:08 AM - 9:13 AM Why I No Longer Use Surgeon-Modified Endografts For Complex AAAs And TAAAs: Advantages Of Industry-Made Endografts
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Abstract      
9:14 AM - 9:19 AM Advantages And Limitations Of Internally Branched Endografts For Complex AAAs And TAAAs
  Presenter(s):Marcelo Ferreira, MD  
  View Abstract      
9:20 AM - 9:28 AM Panel Discussion
9:28 AM - 9:40 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 27
 
SESSION 28 SCHEDULE
Wednesday
SESSION 28: MORE ABOUT PARALLEL GRAFTS AND F/B GRAFTS FOR AAAs, TAAAs AND COMPLICATIONS OF TBADs
x
9:40 AM - 9:45 AM The Geppetto Technique To Avoid Brachial Access In Complex Endovascular Interventions Requiring Revascularization Of Multiple Branches
  Presenter(s):David J. Minion, MD  
  View Abstract      
9:46 AM - 9:51 AM The Nellix Endovascular Device Can Be Used With Multiple Chimneys For Juxta And Suprarenal AAAs And Ruptured AAAs: How To Do It
  Presenter(s):Ian Loftus, MD  
  View Abstract      
9:52 AM - 9:57 AM The Nellix Device Can Be Used To Treat Juxtarenal Elective And Ruptured AAAs By Employing Parallel Grafts To The Renal Arteries
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Abstract      
9:58 AM - 10:03 AM Gore Hybrid Grafts To Facilitate Visceral Debranching In Complex Hybrid Aortic Aneurysm Repairs
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Abstract      
10:04 AM - 10:09 AM The Gutter Killer: A New Catheter For Embolization Of Gutter Endoleaks In Parallel Grafts
  Presenter(s):Martin Malina, MD, PhD  
  View Abstract      
10:10 AM - 10:15 AM What Are Frequently Encountered Problems With F/B Endografts: How Can They Be Prevented And Corrected
  Presenter(s):Tara M. Mastracci, MD  
  View Abstract      
10:16 AM - 10:23 AM Panel Discussion
Moderator(s): Jerry Goldstone, MD, FACS, FRCSEd / Mario Lachat, MD  
10:24 AM - 10:29 AM Mid-Term Outcomes Of Sandwich Grafts For Revascularizing Hypogastric Arteries With Common Iliac Aneurysms
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Abstract      
10:30 AM - 10:35 AM Parallel Grafts (Chimney Or Periscope Grafts) Can Be Used To Revascularize A Critical IMA During EVAR Treatment Of AAAs
  Presenter(s):Ross Milner, MD  
  View Abstract      
10:36 AM - 10:41 AM Technique For Placing Guiding Sheaths, Stents And Stent-Grafts Into Visceral Arteries For Parallel Graft Procedures Complicated By Extreme Tortuosity Or Previous Hardware: How An Aortic Balloon Can Help
  Presenter(s):Jeffrey Y. Wang, MD  
  View Abstract      
10:42 AM - 10:47 AM Parallel Grafts (CHIMPS) For Revascularizing Vital Aortic Branches At All Levels Are Effective: What Is Their Value And Their Limitation
  Presenter(s):Chang Shu, MD  
  View Abstract      
10:48 AM - 10:53 AM Mid And Long-Term Results With Parallel Grafts (CHIMPS) In Complex AAA Repairs: How Good Are They
  Presenter(s):Alan M. Graham, MD  
  View Abstract      
10:54 AM - 10:59 AM A Side-By-Side Computational Flow Dynamic Analysis Of The Various Devices Used For Thoracoabdominal Aneurysm
  Presenter(s):Patrick W. Kelly, MD / Tyler Remund, PhD / Stephen Gent, PhD  
  View Abstract      
11:00 AM - 11:06 AM Panel Discussion
END OF SESSION 28
 
SESSION 29 SCHEDULE
Wednesday
SESSION 29: A TRIBUTE TO OUR MILITARY (8 AND 9-MINUTE TALKS)
x
11:07 AM - 11:16 AM The Doolittle Raiders And 30 Seconds Over Tokyo: What Did Their Skill And Courage Do For The US In World War II
  Presenter(s):Wayne F. Yakes, MD  
  View Abstract      
11:17 AM - 11:25 AM Lessons Learned From Treating Combat Casualties In Our Operations In Iraq And Afghanistan
  Presenter(s):Todd E. Rasmussen, MD, FACS  
  View Abstract      
11:26 AM - 11:34 AM Early Treatment Of Pediatric Vascular Injuries And Mass Casualties: Experience During Humanitarian Surgical Care During US Military Operations In Iraq And Afghanistan
  Presenter(s):Charles J. Fox, MD, FACS  
  View Abstract      
11:35 AM - 11:43 AM Recent Progress In Treating Major Vascular War Wounds
  Presenter(s):Eric Elster, MD  
  View Abstract      
11:44 AM - 11:53 AM What Biomedical Research That Is Important To All Of Us Is Being Conducted Aboard The International Space Station
  Presenter(s):Lee M. Morin, MD, PhD  
  View Abstract      
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 29
 
SESSION 30 SCHEDULE
Wednesday
SESSION 30: NEW CONCEPTS, DIFFERING VIEWPOINTS, CONTROVERSIES IN VASCULAR DISEASE AND ITS TREATMENT
x
1:00 PM - 1:05 PM Appropriate Genome-Based Antiplatelet Treatment Should Be A Prerequisite For All Interventional Treatments
  Presenter(s):Karthikeshwar Kasirajan, MD  
  View Abstract      
1:06 PM - 1:11 PM Combined Anatomic-Functional Testing With Coronary CT Angiography And Functional Flow Dynamics Is A Game Changer In Evaluating Cardiac Status In Vascular Patients: It Will Replace All Other Diagnostic Tests
  Presenter(s):Christopher K. Zarins, MD  
  View Abstract      
1:12 PM - 1:17 PM Value Of Biomarkers For Arteriosclerosis In Predicting Cardiac Risk In Vascular Patients
  Presenter(s):Peter Henke, MD  
  View Abstract      
1:18 PM - 1:23 PM Monocyte Phenotyping: A Sensitive Biomarker For Predicting Adverse Vascular Events
  Presenter(s):John P. Fletcher, MD  
  View Abstract      
1:24 PM - 1:29 PM Update On The RCT Of Venous Balloon Angioplasty Of Venous Balloon Angioplasty vs. Venography Placebo: What Does It Tell Us
  Presenter(s):L. Nelson Hopkins, MD  
  View Abstract      
1:30 PM - 1:35 PM What Is SPY Technology And How Can It Help Vascular Specialists And Vascular Patients
  Presenter(s):Wei Zhou, MD  
  View Abstract      
1:36 PM - 1:41 PM DEBATE: Off Label Use Of EVAR Devices Leads To Higher Failure Rates
  Presenter(s):Andres Schanzer, MD  
  View Abstract      
1:42 PM - 1:47 PM DEBATE: Not So! Off-Label Use Of Newer EVAR Devices Does Not Lead To Higher Failure Rates: Why The Discrepancy
  Presenter(s):B. Patrice Mwipatayi, FRACS  
  View Abstract      
1:48 PM - 1:53 PM Saccular AAAs Behave Differently From Fusiform AAAs Of The Same Diameter: How Should It Influence Our Treatment: Is There Proof
  Presenter(s):Jacques Busquet, MD  
  View Abstract      
1:54 PM - 1:59 PM DEBATE: How Far Should We Go With Endovascular Treatment Of Challenging CTOs Causing CLI: An Interventionalist’s Point Of View
  Presenter(s):Craig M. Walker, MD  
  View Abstract      
2:00 PM - 2:05 PM DEBATE: How Far Should We Go With Endovascular Treatment Of Challenging CTOs Causing CLI: An Endocompetent Vascular Surgeon’s View
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Abstract      
2:06 PM - 2:13 PM Panel Discussion
END OF SESSION 30
 
SESSION 31 SCHEDULE
Wednesday
SESSION 31: NEW DATA ON MULTILAYER FLOW MODULATING (MLFM) BARE STENTS IN THE TREATMENT OF ANEURYSMS AND DISSECTIONS
x
2:13 PM - 2:18 PM Update On The Value Of MLFM Uncovered Stents In The Treatment Of Visceral And Popliteal Aneurysms: Do They Shrink: Have Any Ruptured
  Presenter(s):Claudio Rabbia, MD / Maria Antonella Ruffino, MD  
  View Abstract      
2:19 PM - 2:24 PM Endovascular Treatment Of Complex Thoracic Aortic Aneurysm With Multiple Overlapping Bare Stents Can Decrease Spinal Cord Ischemia (SCI) And Result In Decreased Aneurysm Size: When Is This Treatment Appropriate
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Abstract      
2:25 PM - 2:30 PM Continuing Impressions Of The Value Of MLFM Bare Stents In Treating Complex Aortic Aneurysms
  Presenter(s):Edward B. Diethrich, MD  
  View Abstract      
2:31 PM - 2:36 PM Mechanisms Whereby MLFM Bare Stents Could Prevent Aneurysm Rupture: Do They Work
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Abstract      
2:37 PM - 2:42 PM Brazilian Experience With MLFM Stents In The Treatment Of Aortic Aneurysms
  Presenter(s):Daniel Benitti, MD  
  View Abstract      
2:43 PM - 2:48 PM 3-Year Results Of The French Registry Of MLFM Stents In The Treatment Of Thoracic And Abdominal Complex Aortic Aneurysms
  Presenter(s):Claude D. Vaislic, MD  
  View Abstract      
2:49 PM - 2:54 PM Value And Limitations Of The MLFM Stent In Treating Arch Aneurysms And Dissections
  Presenter(s):Erno Remsey-Semmelweis, MD, PhD  
  View Abstract      
2:55 PM - 3:00 PM Pros And Cons Of MLFM Stents For The Treatment Of Complex Aortic Aneurysms: A Balanced View And Is Sac Thrombosis Good Or Bad For Aneurysm Wall Integrity And Rupture: What Is The Mechanism
  Presenter(s):Frans L. Moll, MD, PhD  
  View Abstract      
3:01 PM - 3:06 PM Advantages And Limitations Of MLFM Stents For Aortic Aneurysm Treatment: When Do They Work And When Don’t They: Results Of The German Registry
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Abstract      
3:07 PM - 3:12 PM DEBATE: The MLFM Device Is A Disruptive Technology For Aortic Aneurysm And Dissection Based On The Results Of A Global Registry
  Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC  
  View Abstract      
3:13 PM - 3:18 PM DEBATE: MLFM Stents Are Not An Effective Treatment For Complex Aortic Aneurysm And Do Not Prevent Sac Growth And Rupture
  Presenter(s):Thomas Larzon, MD, PhD  
  View Abstract      
3:19 PM - 3:29 PM Panel Discussion
3:30 PM - 3:40 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 31
 
SESSION 32 SCHEDULE
Wednesday
SESSION 32: NEW DEVELOPMENTS IN ROBOTICS, ENDOVASCULAR GUIDANCE, ENDOSCOPY ACCESS AND OTHER IMPROVED TECHNOLOGY
x
IMPROVED ROBOTIC GUIDANCE
3:40 PM - 3:45 PM Experience With Improved Lower Profile Robotic Catheter Techniques: They Facilitate Many Endovascular Procedures Including Complex Embolizations
  Presenter(s):Barry T. Katzen, MD  
  View Abstract      
3:46 PM - 3:51 PM How Can Robotic Navigation Be Combined With 3D Imaging To Make Complex Endovascular Procedures Easier, Quicker And More Predictable With Complex Anatomy: How Does the 6 French System Help
  Presenter(s):Alan B. Lumsden, MD, FACS  
  View Abstract      
3:52 PM - 3:57 PM How Can Robotic Assistance And Guidance Be Helpful With Complex Anatomy For CAS And F/B EVAR: What About Radiation Exposure
  Presenter(s):Nicholas J.W. Cheshire, MD / Celia Riga, MD  
  View Abstract      
3:58 PM - 4:03 PM What Does The ROVER Registry Tell Us About Advantages Of Robotic Catheter Based Procedures: Faster, Less Arterial Wall Trauma, Decreased Radiation Exposure, Improved Crossing Of Difficult CTOs
  Presenter(s):Jean Bismuth, MD  
  View Abstract      
4:04 PM - 4:09 PM Minimally Invasive Treatment Of Paget-Schroetter Disease With EKOS Ultrasound Assisted Thrombolysis And Robot Assisted First Rib Resection: How The Robot Helps
  Presenter(s):Hans M.E. Coveliers, MD, MBA  
  View Abstract      
4:10 PM - 4:15 PM The Truth About Endoscopic Vein Harvest: Is It Worthwhile: Based On VQI Observations
  Presenter(s):Fred A. Weaver, MD  
  View Abstract      
4:16 PM - 4:21 PM Tips And Tricks For Radial Access For Lower Extremity And Other Remote Lesion Treatments: Equipment Required
  Presenter(s):Marcelo Guimaraes, MD  
  View Abstract      
4:22 PM - 4:27 PM Update With New Simplified Aortic Occlusion Balloon For Ruptured AAAs And Other Hemorrhagic Emergencies: Advantages, Limitations And Clinical Experience: Scoring System To Help Tell Us Which Ruptured AAAs Should Not Be Treated
  Presenter(s):Benjamin W. Starnes, MD  
  View Abstract      
4:28 PM - 4:33 PM When Can Improved Duplex Ultrasound Replace Contrast CTA For Post-EVAR Surveillance And Detecting Failing Lower Extremity Stent-Grafts
  Presenter(s):Keith D. Calligaro, MD  
  View Abstract      
4:34 PM - 4:40 PM Panel Discussion
END OF SESSION 32
 
SESSION 33 SCHEDULE
Wednesday
SESSION 33: NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED AAAs
x
4:40 PM - 4:45 PM 100% Of Ruptured AAAs (RAAAs) Can Be Treated Endovascularly If Chimney, Periscopes And Other Adjuncts Are Used: Turn-Down Rates Are Low And Early Mortality Is Low
  Presenter(s):Dieter O. Mayer, MD / Thomas Larzon, MD, PhD / Mario Lachat, MD  
  View Abstract      
THE RECENT RCTS OF RAAAS: FACTS AND FLAWS – A MEGA DEBATE
4:46 PM - 4:51 PM Results From The French ECAR RCT Results Comparing EVAR With Open Repair For RAAAs
  Presenter(s):Pascal Desgranges, MD, PhD  
  View Abstract      
4:52 PM - 4:57 PM Results From The Dutch AJAX RCT Comparing EVAR With Open Repair For RAAAs
  Presenter(s):Willem Wisselink, MD  
  View Abstract      
4:58 PM - 5:03 PM Early Results From The UK IMPROVE Trial Comparing An EVAR Strategy With Open Repair For RAAAs: It Shows That The EVAR Strategy Has No Lower Early Mortality Than Open Repair
  Presenter(s):Janet T. Powell, MD, PhD  
  View Abstract      
WHY THE RCTS ARE MISLEADING
5:04 PM - 5:09 PM IMPROVE Trial Is A Laudable Study, But Its Conclusion Is Flawed: EVAR Is Better Than Open Repair For RAAAs
  Presenter(s):Frank J. Veith, MD  
  View Abstract      
5:10 PM - 5:15 PM The 3 Recent RAAA RCTs Are Flawed And Misleading: What Are These Flaws
  Presenter(s):Nicholas J.W. Cheshire, MD  
  View Abstract      
5:16 PM - 5:21 PM EVAR Is Clearly Better Than Open Repair And We Do Not Need An RCT To Prove It
  Presenter(s):Mario Lachat, MD  
  View Abstract      
5:22 PM - 5:27 PM The Recent RCTs Comparing EVAR To Open Repair For RAAAs Are Misleading And We Do Not Need More RCTs To Prove EVAR Is Better
  Presenter(s):Thomas Larzon, MD, PhD  
  View Abstract      
OTHER OPINIONS AND DATA
5:28 PM - 5:33 PM EVAR Clearly Should Be The First Treatment Choice For RAAAs: We Don’t Need More Trials To Prove It
  Presenter(s):Edward B. Diethrich, MD / Julio A. Rodriguez-Lopez, MD  
  View Abstract      
5:34 PM - 5:39 PM Does A Fixed Protocol For Treating Ruptured AAAs By EVAR Improve Outcomes: Based On A Prospective Multicenter Registry Results
  Presenter(s):Kim J. Hodgson, MD  
  View Abstract      
5:40 PM - 5:45 PM Meta-Analysis Of Recent RCTs Comparing EVAR With Open Repair For Ruptured AAAs: It Is Level 1A Evidence, But It May Be Misleading
  Presenter(s):Ron Balm, MD, PhD  
  View Abstract      
5:46 PM - 5:51 PM Long-Term Survival Of Ruptured AAAs Is Better After EVAR Than After Open Repair: The Early Survival Benefit Of EVAR Persists Beyond 5 Years
  Presenter(s):Dieter O. Mayer, MD / Mario Lachat, MD / Frank J. Veith, MD / Zoran Rancic, MD, PhD  
  View Abstract      
5:52 PM - 5:57 PM Why Are Treatment Outcomes For RAAAs Better In The US Than In The UK: Hints For Improving Results And Support For The Position That EVAR Is Better Than Open Repair
  Presenter(s):Matt M. Thompson, MD  
  View Abstract      
5:58 PM - 6:08 PM Panel Discussion

End of Program D

END OF SESSION 33
 
SESSION 34 SCHEDULE
Wednesday
SESSION 34: NEW FINDINGS AND INFORMATION ON THE TREATMENT OF POPLITEAL ANEURYSM
x
6:45 AM - 6:50 AM What Are The Real Results Of Endovascular Popliteal Aneurysm Repair: When Is It Indicated And When Contraindicated
  Presenter(s):Sonia Ronchey, MD, PhD  
  View Abstract      
6:51 AM - 6:56 AM Anatomic Features That Predict Complications Of Endovascular Aneurysm Repair And When It Is Contraindicated
  Presenter(s):Thomas L. Forbes, MD  
  View Abstract      
6:57 AM - 7:02 AM The Modern Treatment Of Popliteal Aneurysms Varies Widely: Why Is This So: Value Of Thrombolysis: What Is The Best Surgical Approach
  Presenter(s):Martin Bjorck, MD, PhD  
  View Abstract      
7:03 AM - 7:08 AM Long-Term Outcomes And Sac Shrinkage After Endovascular Popliteal Aneurysm Repair: What Are The Implications
  Presenter(s):Franco Grego, MD / Giovanni P. Deriu, MD  
  View Abstract      
7:09 AM - 7:14 AM Avoidance And Treatment Of Complications After Endografting For Popliteal Aneurysm
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
  View Abstract      
7:15 AM - 7:20 AM Popliteal Aneurysm Treatment: When Endo, When Open: Technical Tips: Primary And Secondary Patency Results; Reintervention Is Not Always Required For Graft Failure
  Presenter(s):Neal S. Cayne, MD  
  View Abstract      
THREE-PART DEBATE
7:21 AM - 7:26 AM DEBATE: Endovascular Treatment Is Inferior For Popliteal Aneurysms Needing Treatment
  Presenter(s):Werner Lang, MD  
  View Abstract      
7:27 AM - 7:32 AM DEBATE: Some Popliteal Aneurysms Should Be Treated Endo; Some Open
  Presenter(s):Bauer E. Sumpio, MD, PhD  
  View Abstract      
7:33 AM - 7:38 AM DEBATE: Almost All Popliteal Aneurysms Can Be Treated Endovascularly: Technical Considerations And Outcomes: What Was The Outcome Of The Former Vice President's Large Popliteal Aneurysm Repairs In 2004
  Presenter(s):Barry T. Katzen, MD  
  View Abstract      
7:39 AM - 7:44 AM Panel Discussion
END OF SESSION 34
 
SESSION 35 SCHEDULE
Wednesday
SESSION 35: NEW DEVELOPMENTS IN THE TREATMENT OF INFECTED AORTIC GRAFTS AND ENDOGRAFTS; VALUE OF EVAR FOR MYCOTIC ANEURYSMS
x
7:45 AM - 7:50 AM Update On Silver/Triclosan Synergy Prosthesis For In Situ Replacement Of Infected Aortic Prostheses: They Really Work Based On The SATIGI Registry And Other Data
  Presenter(s):Max Zegelman, MD  
  View Abstract      
7:51 AM - 7:56 AM Endovascular Treatment Of Mycotic AAAs: When Does It Work And For How Long: Based On 132 Cases With Long Follow-up
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Abstract      
7:57 AM - 8:02 AM When Are Endografts The Best Treatment For Aortic Infection And When Are They Not
  Presenter(s):Francesco Setacci, MD  
  View Abstract      
8:03 AM - 8:08 AM Conservative Treatment Of Endograft Infection After EVAR With CT Guided Drainage And Graft Preservation: When Can It Work And When Can It Not
  Presenter(s):Kamphol Laohapensang, MD  
  View Abstract      
8:09 AM - 8:14 AM Treatment Of Para And Suprarenal Aortic Graft Infection: Do Endografts Play A Role
  Presenter(s):Manju Kalra, MBBS  
  View Abstract      
8:15 AM - 8:20 AM Technical Tips For Removing An Infected Endograft: It Is Not Simple
  Presenter(s):Thomas C. Bower, MD  
  View Abstract      
8:21 AM - 8:26 AM EVAR Can Be Effective Treatment For Infected Aneurysms In All Parts Of The Aorta With Both Simple And Complex Anatomies: Chimney Grafts May Be Needed: How To Do It Successfully And Get Long-Term Survival
  Presenter(s):Boonprasit Kritpracha, MD  
  View Abstract      
8:27 AM - 8:32 AM DEBATE: Management Of Mycotic Aneurysms And Infected Stent-Grafts After EVAR And TEVAR: Infected Endografts Must Come Out
  Presenter(s):Piotr M. Kasprzak, MD  
  View Abstract      
8:33 AM - 8:38 AM DEBATE: Not So: A New Treatment Paradigm For Treating Infected Endografts After EVAR And Mycotic Aneuryms May Allow Endograft Preservation
  Presenter(s):Martin Malina, MD, PhD  
  View Abstract      
8:39 AM - 8:44 AM How To Treat Mycotic Thoracic Aneurysms
  Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD  
  View Abstract      
8:45 AM - 8:52 AM Panel Discussion
END OF SESSION 35
 
SESSION 36 SCHEDULE
Wednesday
SESSION 36: EXCITING NEW DEVELOPMENTS IN THE MEDICAL TREATMENT OF VASCULAR DISEASE
x
8:52 AM - 8:57 AM Do Atherosclerotic Plaques Regress: How And Why: What Are The Implications For Treatment
  Presenter(s):Ralph G. DePalma, MD  
  View Abstract      
8:58 AM - 9:03 AM How Can The Medical Treatment Of Arteriosclerosis Be Improved: Should More Patients Receive Statins: Do HDL Levels Matter: Does Elevating A Low HDL Level Help In Any Way: What Is On The Horizon For Improving Drug Or Medical Treatment For Arteriosclerosis
  Presenter(s):Don Poldermans, MD  
  View Abstract      
9:04 AM - 9:09 AM What Do The New AHA Cholesterol Guidelines And The New Information About Beta Blockers Mean To Vascular Surgeons
  Presenter(s):Peter Henke, MD  
  View Abstract      
9:10 AM - 9:15 AM Medical Therapy In Peripheral Artery Disease: Anything New On The Horizon: What Is The Value Of Chronic PA Pressure Monitoring With The CardioMEMS Implantable Pressure Sensor
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Abstract      
9:16 AM - 9:21 AM Why All Vascular Patients Should Have Perioperative Or Periprocedural Troponins: How Do They Help In Patient Treatment
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Abstract      
9:22 AM - 9:27 AM How Long Should Dual Antiplatelet Treatment Be Continued After Patients Receive A Coronary Stent (BMS Or DES): When Is It Safe To Stop Clopidogrel And Perform Non-Cardiac Surgery – An AAA, A Leg Bypass Or CEA: What To Do If Surgery Cannot Be Delayed: Based On New Findings From The OPTIMIZE Trial
  Presenter(s):Ron Waksman, MD  
  View Abstract      
9:28 AM - 9:33 AM Vitamin D Supplementation And Tight Blood Glucose Control In Diabetics Do Not Have A Major Impact On The Progression Of Vascular Disease: Other Factors Are More Important
  Presenter(s):Erich Minar, MD  
  View Abstract      
9:34 AM - 9:39 AM How To Prevent And Treat Postoperative Delirium After Vascular Surgery
  Presenter(s):Clark J. Zeebregts, MD, PhD  
  View Abstract      
9:40 AM - 9:47 AM Panel Discussion
9:48 AM - 10:00 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 36
 
SESSION 37 SCHEDULE
Wednesday
SESSION 37: NEW DEVELOPMENTS IN ENDOVASCULAR TECHNOLOGY, TECHNIQUES AND THE MEDICAL TREATMENT OF VASCULAR DISEASE
x
10:00 AM - 10:05 AM Imaging With Lower Radiation Exposure Using A Novel Fixed C-Arm System During Endovascular Procedures: The Philips Allura Clarity Hybrid OR
  Presenter(s):Olivier H.J. Koning, MD  
  View Abstract      
10:06 AM - 10:11 AM Unusual Uses Of Re-entry Devices: They Are An Essential Tool
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Abstract      
10:12 AM - 10:17 AM DEBATE: Be Skeptical About The Need For Atherectomy Systems: The New Ones May Be No Better Than The Old Ones
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Abstract      
10:18 AM - 10:23 AM DEBATE: Not So Fast, Leaving Nothing Behind Trumps Any Permanent Device In The SFA: Current Evidence And Clinical Utility Of Atherectomy Systems
  Presenter(s):Lawrence A. Garcia, MD  
  View Abstract      
10:24 AM - 10:29 AM Endovenous Or Perivascular Routes For Internal Prosthetic Bypasses In The SFA And Popliteal Arteries: How Can IVUS And Robotics Help: A New Treatment Concept
  Presenter(s):Alan B. Lumsden, MD, FACS / Tony S. Das, MD  
  View Abstract      
10:30 AM - 10:35 AM Where Do We Stand With Cell Therapy For Ischemia In The Legs; In The Heart
  Presenter(s):Alan Dardik, MD, PhD  
  View Abstract      
10:36 AM - 10:41 AM Tips And Tricks For Endovascular Interventions In Pediatric Patients
  Presenter(s):Furuzan Numan, MD  
  View Abstract      
10:42 AM - 10:47 AM Manifestations And Treatment Of Spontaneous Renal Artery Dissections
  Presenter(s):James C. Stanley, MD  
  View Abstract      
10:48 AM - 10:57 AM Panel Discussion
NEW DEVELOPMENTS IN MEDICAL TREATMENT AND RISK MODIFICATION
Moderator(s): Ron Waksman, MD / Jack L. Cronenwett, MD  
10:57 AM - 11:02 AM How To Improve 5-Year Survival After Vascular Surgery By 25% Or More: Give Proper Doses Of Statins And Antiplatelet Agents
  Presenter(s):Jack L. Cronenwett, MD  
  View Abstract      
11:03 AM - 11:08 AM Preoperative Statin Administration Decreases The Incidence Of Contrast Induced Kidney Injury
  Presenter(s):John H. Rundback, MD, FSIR, FAHA  
  View Abstract      
11:09 AM - 11:14 AM A Frailty Index And What It Can Mean For Vascular Specialists Or Surgeons Interested In Vascular Disease Patients: Is It Better Than The Eyeball Test
  Presenter(s):Gregory L. Moneta, MD  
  View Abstract      
11:15 AM - 11:20 AM Differential Effect Of Arteriosclerotic Risk Factors In Men And Women: Why Does It Matter
  Presenter(s):Caron B. Rockman, MD  
  View Abstract      
11:21 AM - 11:26 AM Cilostazol Is Associated With Improved Outcomes After Vascular Interventions: Should Vascular Specialists Use It And How
  Presenter(s):Richard J. Powell, MD  
  View Abstract      
11:27 AM - 11:32 AM What Test Should We Use To Evaluate Antiplatelet Drugs In Vascular Patients – Especially Those Undergoing A Procedure
  Presenter(s):Frans L. Moll, MD, PhD  
  View Abstract      
11:33 AM - 11:38 AM Importance Of Smoking Cessation Prior To Lower Extremity Bypasses: It Decreases The Failure Rate
  Presenter(s):Christopher J. Abularrage, MD / James H. Black III, MD  
  View Abstract      
11:39 AM - 11:44 AM How To Prevent Cardiovascular Death In Diabetic Patients With CLI And Arteriosclerosis: It Is As Important As Saving The Limb
  Presenter(s):Francesco Liistro, MD  
  View Abstract      
11:45 AM - 11:50 AM Characteristics Of Patients Who Currently Develop Acute Limb Ischemia And What Is Their Long-Term Prognosis
  Presenter(s):Beatrice R. Amann-Vesti, MD  
  View Abstract      
11:51 AM - 0:00 AM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 37
 
SESSION 38 SCHEDULE
Wednesday
SESSION 38: ADVANCES IN IMAGING
x
1:00 PM - 1:05 PM Selective Intra-Arterial CTA For Lower Extremity Occlusive Disease In Patients With Renal Insufficiency: It Decreases Contrast Dose And Is Safe
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Abstract      
1:06 PM - 1:11 PM Advantages Of An Integrated 3-D Imaging Solution For Planning, Fusion And Assessment Of Complex Aortic Procedures
  Presenter(s):Stephan Haulon, MD  
  View Abstract      
1:12 PM - 1:17 PM Aortic Procedures Of The Future Will Mandate 3D Imaging For Planning And Preparation, And For Performing
  Presenter(s):Dittmar Boeckler, MD  
  View Abstract      
1:18 PM - 1:23 PM The Use Of A Computerized Patient Specific Model And MRA Data To Predict Pressure Drops Across Equivocal Stenoses
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Abstract      
1:24 PM - 1:29 PM Precannulation Of Visceral And Renal Arteries Using Fusion Software On The Artis Zeego System During F/B EVAR Is Fast, Simple, And Valuable: How To Do It
  Presenter(s):Neal S. Cayne, MD  
  View Abstract      
1:30 PM - 1:35 PM Value And Implementation Of 3D Ultrasound Scans For All AAA Evaluations: What Can And Should Be Measured: What Equipment Is Needed
  Presenter(s):Henrik Sillesen, MD, DMSc  
  View Abstract      
1:36 PM - 1:41 PM 3D Ultrasound Is The CT Scan Of The Future And Eliminates Radiation Exposure
  Presenter(s):Brajesh K. Lal, MD  
  View Abstract      
1:42 PM - 1:47 PM What New Information Can Be Learned From 3D Ultrasound Of AAAs: How Can It Provide Finite Element Analysis
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
  View Abstract      
1:48 PM - 1:53 PM Panel Discussion
1:54 PM - 1:59 PM What Important Information Can Be Obtained From Transcranial Doppler (TCD) If You Know How To Get It: Wider Use Of TCD Is Justified
  Presenter(s):Zsolt Garami, MD  
2:00 PM - 2:05 PM 3D Holography To Guide Endovascular Interventions: How Does It Work: Can CTA Be Avoided And MRI And 3D Ultrasound Take Its Place
  Presenter(s):Elchanan Bruckheimer, MBBS  
  View Abstract      
2:06 PM - 2:11 PM A Complete Mobile Hybrid Room With Ziehm Vision RFD Hybrid C-Arm And Stille Imagiq2 Floating Table For Complex Endovascular Procedures: Advantages And Limitations Compared To A Fixed Hybrid Room
  Presenter(s):Peter C.J. Goverde, MD  
  View Abstract      
2:12 PM - 2:17 PM DEBATE: Should Duplex Ultrasound Replace CTA For Post EVAR Surveillance: YES, In Most Cases
  Presenter(s):Michel Makaroun, MD  
  View Abstract      
2:18 PM - 2:23 PM DEBATE: Should Duplex Ultrasound Replace CTA For Post EVAR Surveillance: NO, In Most Cases
  Presenter(s):S. Rao Vallabhaneni, MD, FRCS  
  View Abstract      
2:24 PM - 2:29 PM Panel Discussion
END OF SESSION 38
 
SESSION 39 SCHEDULE
Wednesday
SESSION 39: ADVANCES AND UPDATES IN THE TREATMENT OF THORACIC OUTLET SYNDROMES, AN HISTORICAL VIGNETTE AND NEW DEVICES AND CONCEPTS
x
2:29 PM - 2:34 PM New Thoracic Outlet Syndrome (TOS) SVS Reporting Standards: What Is New
  Presenter(s):Karl A. Illig, MD  
  View Abstract      
2:35 PM - 2:40 PM Treatment Of TOS And Popliteal Entrapment In High Performance Athletes: What Is The Role Of Exercise, Physiotherapy And Surgery
  Presenter(s):Jason T. Lee, MD  
  View Abstract      
2:41 PM - 2:46 PM Some Patients With Presumed Neurogenic TOS Really Have Jugular And Subclavian Venous Stenosis: Balloon Angioplasty Can Provide Symptom Relief
  Presenter(s):Sam S. Ahn, MD, FACS, MBA  
  View Abstract      
2:47 PM - 2:52 PM Current Optimal Treatment For Arterial Compression At The Thoracic Outlet
  Presenter(s):Enrique Criado, MD, FACS  
  View Abstract      
2:53 PM - 2:58 PM Historical Vignette: The First Endoleak And The First AAA Repair By Norman Freeman – Before Charles Dubost’s
  Presenter(s):Christopher K. Zarins, MD  
  View Abstract      
2:59 PM - 3:04 PM Infrared IVUS: A New Technique For Detecting Vulnerable Plaque
  Presenter(s):Ron Waksman, MD  
  View Abstract      
3:05 PM - 3:10 PM Early Experience With A New Improved Digital Mobile C-Arm: The Cios Alpha System From Siemens: Advantages And Limitations
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Abstract      
3:11 PM - 3:16 PM Panel Discussion
3:17 PM - 3:30 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 39
 
SESSION 40 SCHEDULE
Wednesday
SESSION 40: NEW CONCEPTS, TECHNIQUES, UPDATES
x
3:30 PM - 3:35 PM Value And Limitations Of Optical Coherence Tomography For Use In Lower Extremity Vascular Assessment And Treatments
  Presenter(s):Vikram S. Kashyap, MD  
  View Abstract      
3:36 PM - 3:41 PM Sensible And Extreme Approach To Limb Preservation (The SEAL Approach): Who And What Is Involved And What Are The Benefits: Should There Be SEAL Centers
  Presenter(s):Niten Singh, MD  
  View Abstract      
3:42 PM - 3:47 PM The Chocolate Balloon: A New Better Less Traumatic Drug Coated Balloon For Dilating Arterial Lesions With Less Dissection: Mode Of Action, Advantages And Clinical Experience
  Presenter(s):Jihad A. Mustapha, MD  
  View Abstract      
3:48 PM - 3:53 PM Does Prostate Endovascular Embolization Work: For What Conditions: Advantages And Limitations
  Presenter(s):Jörn O. Balzer, MD, PhD  
  View Abstract      
3:54 PM - 3:59 PM Pathophysiology Of Hand And Finger Ischemia In Hemodialysis Patients And How It Can Best Be Treated
  Presenter(s):Roberto Ferraresi, MD  
  View Abstract      
4:00 PM - 4:05 PM Update On Tissue Engineered Arterial Prostheses: Progress And Remaining Challenges
  Presenter(s):Elliot L. Chaikof, MD, PhD  
  View Abstract      
4:06 PM - 4:11 PM For Recanalizing Lower Extremity CTOs Above And Below The Knee, Simpler And Cheaper Devices Are Better: It Does Not Matter Whether The Route Is Intraluminal Or Subintimal
  Presenter(s):Amman Bolia, MD  
  View Abstract      
4:12 PM - 4:17 PM Will DEBs Become The Gold Standard For Dilating Bare Metal Stents (BMSs) In The SFA: Will This Strategy Be Cost Effective
  Presenter(s):Stefan Mueller-Hülsbeck, MD  
  View Abstract      
4:18 PM - 4:23 PM Current Optimal Techniques For Minimizing Contrast Induced Nephropathy After Angiographic Procedures
  Presenter(s):Jonathan R. Boyle, MD, FRCS  
  View Abstract      
4:24 PM - 4:29 PM Quantitative Determination Of Respiratory Movement Of Aorta And Side Branches In Image Fusion Guidance: How Can It Improve Branch Origin Location Accuracy And Minimize Errors
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
  View Abstract      
4:30 PM - 4:35 PM Underutilization Of Statins In CLI Patients: Statins Keep The Patient Alive Longer And Decrease Amputation Rates After Open And Endo Revascularization Procedures
  Presenter(s):Todd R. Vogel, MD, MPH  
  View Abstract      
4:36 PM - 4:41 PM Diagnosis And Management Of Vascular Complications In Athletes
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
  View Abstract      
4:42 PM - 4:50 PM Panel Discussion
END OF SESSION 40
 
SESSION 41 SCHEDULE
Wednesday
SESSION 41: NEW CONCEPTS IN ENDOVASCULAR TREATMENT AND MANAGEMENT OF COMPLICATONS; MORE INFORMATION ABOUT RENAL DENERVATION AND OTHER WAYS TO TREAT RESISTANT HYPERTENSION; AMPUTATIONS
x
4:50 PM - 4:55 PM We Don’t Need More Endovascular Treatments: Just Better Use Of The Ones We Have
  Presenter(s):Manj S. Gohel, MD, FRCS  
  View Abstract      
4:56 PM - 5:01 PM AAA Wall Microvasculature: How Does It Relate To Thrombus Formation And AAA Growth
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
  View Abstract      
5:02 PM - 5:07 PM Hypercoagulable Testing Is Far Overused In Vascular Patients Whose Revascularizations Fail Repeatedly: What Should We Do To Evaluate Such Patients And When Is Such Testing Helpful
  Presenter(s):Elna M. Masuda, MD  
  View Abstract      
5:08 PM - 5:13 PM A New Simple Technique For Perfusing The Lower Limb To Prevent Ischemia During Prolonged Sheath Obstruction Of The Femoral Arteries During F/B EVAR
  Presenter(s):Johannes Kalder, MD  
  View Abstract      
5:14 PM - 5:19 PM Total Percutaneous Axillary Artery Access In Complex Endovascular Aortic Repair: Technical Tips And Precautions
  Presenter(s):Barend M.E. Mees, MD, PhD  
  View Abstract      
MORE TOPICS ON RESISTANT HYPERTENSION
5:20 PM - 5:25 PM With Respect To Renal Denervation, Where Do The Renal Sympathetic Nerves Lie With Respect To The Renal Artery: Can Radiofrequency (RF) And Ultrasound Inactivate Them And What Effect Do These Modalities Have On The Renal Artery
  Presenter(s):Renu Virmani, MD  
  View Abstract      
5:26 PM - 5:31 PM Is An Arteriovenous Anastomosis The Way To Cure Resistant Hypertension: How Does It Work And Results Of The ROX Arteriovenous Coupler Trial
  Presenter(s):Melvin D. Lobo, MBChB, PhD, FRCP  
  View Abstract      
5:32 PM - 5:37 PM Percutaneous Creation Of An A-V Fistula With The ROX Device: Can It Treat Resistant Hypertension And Other Conditions
  Presenter(s):David H. Deaton, MD  
  View Abstract      
5:38 PM - 5:43 PM Is There A Role For Chemoablation For Renal Denervation
  Presenter(s):Mark H. Wholey, MD / Michael H. Wholey, MD, MBA  
  View Abstract      
5:44 PM - 5:49 PM Why The Negative Results Of SIMPLICITY III Are No Surprise: It Does Not Mean The Field Is Dead: Predictions For The Future
  Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD  
  View Abstract      
5:50 PM - 6:00 PM Panel Discussion

End of Program E

END OF SESSION 41
 
SESSION 42 SCHEDULE
Wednesday
SESSION 42: MANAGEMENT OF PULMONARY EMBOLISM: THE SPECTRUM AS IT EVOLVES – DRUGS, DEVICES AND SURGERY – PART 1
Moderators:Michael R. Jaff, DO  
x
7:00 AM - 7:05 AM Introduction To The Symposium
  Presenter(s):Frank J. Veith, MD  
7:05 AM - 7:15 AM Welcome And Introduction
  Presenter(s):Michael R. Jaff, DO  
7:15 AM - 7:25 AM The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers
  Presenter(s):Ido Weinberg, MD, MSc  
  View Abstract      
7:25 AM - 7:35 AM The Basics Of Echocardiography For PE: What Must The Vascular Specialist Know, And Is An Emergent Echo Necessary
  Presenter(s):David M. Dudzinski, MD  
  View Abstract      
7:35 AM - 7:50 AM What Is State-of-the-Art Medical Therapy For PE
  Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM  
  View Abstract      
7:50 AM - 8:00 AM Intravenous Thrombolytic Therapy For PE: Do We Know More In 2014
  Presenter(s):Christopher Kabrhel, MD, MPH  
  View Abstract      
8:00 AM - 8:10 AM Catheter-Directed Thrombolysis For PE: A Better Lytic Alternative?
  Presenter(s):Jason T. Salsamendi, MD  
  View Abstract      
8:10 AM - 8:25 AM Percutaneous Pharmacomechanical Intervention For PE: What Does The Data Say, And Where Must We Go From Here
  Presenter(s):Iris Baumgartner, MD  
  View Abstract      
8:25 AM - 8:35 AM Lysis For PE: What About The Nuts And Bolts – Heparin, PTT And Fibrinogen Monitoring, And How Do You Know When You Are Done
  Presenter(s):Raghu Kolluri, MD  
  View Abstract      
8:35 AM - 8:45 AM Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It?
  Presenter(s):Jeffrey Y. Wang, MD  
  View Abstract      
Moderator(s): Michael R. Jaff, DO  
8:45 AM - 9:15 AM Case Presentations / Panel Discussion / Questions And Answers
  Panelist(s): Christopher Kabrhel, MD, MPH / Iris Baumgartner, MD / Geno J. Merli, MD, MACP, FHM, FSVM / Jason T. Salsamendi, MD / Jeffrey Y. Wang, MD  
  View Abstract      
9:15 AM - 9:45 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 42
 
SESSION 43 SCHEDULE
Wednesday
SESSION 43: MANAGEMENT OF PULMONARY EMBOLISM: THE SPECTRUM AS IT EVOLVES – DRUGS, DEVICES AND SURGERY – PART 2
Moderators:Michael R. Jaff, DO  
x
9:45 AM - 10:00 AM The SEATTLE Trial: A Breakthrough For PE Treatment?
  Presenter(s):Gregory Piazza, MD, MS  
  View Abstract      
10:00 AM - 10:10 AM What Did The SEATTLE Trial Fail To Answer?
  Presenter(s):Clifford M. Sales, MD, MBA  
  View Abstract      
10:10 AM - 10:20 AM Vortex Strategy For Massive PE
  Presenter(s):Christopher J. Kwolek, MD  
  View Abstract      
10:20 AM - 10:35 AM ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why?
  Presenter(s):Thoralf Sundt, MD  
  View Abstract      
10:35 AM - 10:45 AM What Is The Modern Algorithm For Management Of Massive And Submassive PE
  Presenter(s):Tod C. Engelhardt, MD  
  View Abstract      
10:45 AM - 11:00 AM Iliac Venous Stenosis: When To Look And When To Stent
  Presenter(s):John A. Kaufman, MD  
  View Abstract      
11:00 AM - 11:15 AM The Team Approach To PE Management: The Emergence Of National PERT Centers
  Presenter(s):Kenneth Rosenfield, MD  
  View Abstract      
11:15 AM - 11:45 AM Challenging Cases And “PERT” Decisions
  Panelist(s): Tod C. Engelhardt, MD / John A. Kaufman, MD / Christopher J. Kwolek, MD / Gregory Piazza, MD, MS / Kenneth Rosenfield, MD / Thoralf Sundt, MD  
  View Abstract      
11:45 AM - 12:00 PM Questions And Answers
12:00 PM - 1:00 PM Lunch Break
Visit Exhibits and Pavilions (2nd and 3rd Floors)

END OF SESSION 43
 
SESSION 44 SCHEDULE
Wednesday
SESSION 44: OCCLUSION OF THE DEEP VEINS OF THE LEG: CAUSES, RISKS TO THE PATIENT, AND OPPORTUNITIES FOR TREATMENT
x
1:00 PM - 1:05 PM Large Vein Occlusive Disease: The Magnitude Of The Problem In The Population
  Presenter(s):Peter Gloviczki, MD  
  View Abstract      
1:06 PM - 1:11 PM Physiology Of Large Vein Occlusion: A Hemodynamic Explanation For The Post-Thrombotic Syndrome
  Presenter(s):Mark H. Meissner, MD  
  View Abstract      
1:12 PM - 1:17 PM Predictors Of Post-Thrombotic Syndrome After DVT: Which Patients Will Have Problems
  Presenter(s):Susan R. Kahn, MD, MSc  
  View Abstract      
1:18 PM - 1:23 PM DVT In The Leg: New Modalities For Managing A Lifelong Problem For The Patient
  Presenter(s):Gerard J. O'Sullivan, MD  
  View Abstract      
1:24 PM - 1:29 PM Venous Thrombosis: Can We Determine The Age Of The Thrombus And Does It Matter Anyway
  Presenter(s):Cees H.A. Wittens, MD, PhD  
  View Abstract      
1:30 PM - 1:35 PM DEBATE: Chronic Femoral DVT Should Not Be Treated With Aggressive Interventions
  Presenter(s):John Blebea, MD, MBA  
  View Abstract      
1:36 PM - 1:41 PM DEBATE: Endovascular Interventions Work For Chronic Femoral Occlusions And Should Be Considered In Most Patients
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
1:42 PM - 1:47 PM 2014: The Forefront Of New Anticoagulants For DVT
  Presenter(s):Jeffrey W. Olin, DO  
  View Abstract      
1:48 PM - 1:53 PM Femoral Vein Excision For Vascular Reconstruction: Techniques To Minimize Post-Thrombotic Symptoms
  Presenter(s):Timur P. Sarac, MD  
  View Abstract      
1:54 PM - 1:59 PM Panel Discussion
END OF SESSION 44
 
SESSION 45 SCHEDULE
Wednesday
SESSION 45: ACUTE LOWER EXTREMITY DVT: AVOIDING EARLY AND LATE ADVERSE OUTCOMES
x
2:00 PM - 2:05 PM Risk Of Pulmonary Embolism With DVT: Which Clots, Who And When
  Presenter(s):Michael R. Jaff, DO  
  View Abstract      
2:06 PM - 2:11 PM The Bull’s Eye Sign: A New Iliac Vein Marker To Avert The Need For IVUS
  Presenter(s):Enrico Ascher, MD  
  View Abstract      
2:12 PM - 2:17 PM Thrombolysis For Acute Deep Venous Thrombosis: Is It Safe, Is It Effective: Lessons From The 2014 Cochrane Update
  Presenter(s):Cynthia K. Shortell, MD  
  View Abstract      
2:18 PM - 2:23 PM The EKOS System For Treatment Of Acute DVT: Theory And Practice
  Presenter(s):Anil P. Hingorani, MD  
  View Abstract      
2:24 PM - 2:29 PM Newer Methods For Treating Acute DVT: Thrombolysis, Ultrasound, And Mechanical Thrombectomy Devices
  Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA  
  View Abstract      
2:30 PM - 2:35 PM Update On The ATTRACT Study Of rt-PA For Acute DVT
  Presenter(s):Suresh Vedantham, MD  
  View Abstract      
2:36 PM - 2:41 PM DEBATE: Early Intervention Is Best For Acute Iliofemoral DVT And Prevents Post-Thrombotic Complications
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Abstract      
2:42 PM - 2:47 PM DEBATE: Antithrombotic Therapy Alone For Acute DVT: Lack Of High Level Evidence For Endovenous Interventions
  Presenter(s):Jeffrey W. Olin, DO  
  View Abstract      
2:48 PM - 2:56 PM Panel Discussion
2:56 PM - 3:15 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 45
 
SESSION 46 SCHEDULE
Wednesday
SESSION 46: NOVEL BALLOONS, STENTS, THROMBOLYSIS, ULTRASOUND, AND MECHANICAL THROMBECTOMY DEVICES FOR LARGE VEIN OCCLUSIONS
x
3:16 PM - 3:21 PM Dedicated Stents For The Venous System: Requirements And Status Of Devices In Clinical Development
  Presenter(s):Gerard J. O'Sullivan, MD  
  View Abstract      
3:22 PM - 3:27 PM DEBATE: Currently Marketed Stents Are Suboptimal In The Venous System: The Need For New Devices Engineered For The Veins
  Presenter(s):Cees H.A. Wittens, MD, PhD  
  View Abstract      
3:28 PM - 3:33 PM DEBATE: New Devices Are Encouraged But Stent Malfunctions Are Rare In The Venous System, Even With Older Devices
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
3:34 PM - 3:39 PM Should Drug-Eluting Balloons Be Considered For Large Vein Stenoses: Theory And Predictions For The Future
  Presenter(s):William A. Gray, MD  
  View Abstract      
3:40 PM - 3:45 PM Iliofemoral DVT In Pregnancy: Thrombus Removal Is Safe And Avoids Long-Term Morbidity
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Abstract      
3:46 PM - 3:51 PM Long-Term Outcomes After Trellis Thrombectomy For DVT
  Presenter(s):Rabih A. Chaer, MD  
  View Abstract      
3:52 PM - 3:57 PM Tips And Tricks For Recanalization Of Occluded Large Veins: The Role Of The Ekosonic System
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Abstract      
3:58 PM - 4:03 PM DEBATE: Ultrasound-Enhanced Thrombolysis Yields No Benefit Over Thrombolysis Alone
  Presenter(s):Iris Baumgartner, MD  
  View Abstract      
4:04 PM - 4:09 PM DEBATE: Nonsense; EKOS Thrombolysis For Acute DVT Is A Game Changer
  Presenter(s):Mark J. Garcia, MD  
  View Abstract      
4:10 PM - 4:15 PM Panel Discussion
END OF SESSION 46
 
SESSION 47 SCHEDULE
Wednesday
SESSION 47: TREATMENT OF INFERIOR VENA CAVA THROMBUS, MALIGNANCY, INJURY AND OCCLUSION
x
4:16 PM - 4:21 PM Treatment Of Chronic IVC Occlusion With Stents: Which Patients, Which Stents, And Results
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
4:22 PM - 4:27 PM IVC Resection And Reconstruction For Malignancy: Tips And Tricks
  Presenter(s):William J. Quinones-Baldrich, MD  
  View Abstract      
4:28 PM - 4:33 PM Aggressive Management Of Acute Thrombosis Of The Inferior Vena Cava
  Presenter(s):Bo G. Eklof, MD, PhD  
  View Abstract      
4:34 PM - 4:39 PM Robotic Removal Of Malfunctioning IVC Filters: A Case And Potential For The Future
  Presenter(s):Samuel R. Money, MD, MBA  
  View Abstract      
4:40 PM - 4:45 PM Exsanguinating Hemorrhage From Iatrogenic IVC Injury: Presentation, Management And Outcome
  Presenter(s):Peter Gloviczki, MD  
  View Abstract      
4:46 PM - 4:51 PM Getting Paid For Inferior Vena Caval Procedures: Newer CPT Codes And When To Use Them
  Presenter(s):Sean P. Roddy, MD  
  View Abstract      
4:52 PM - 5:00 PM Panel Discussion
END OF SESSION 47
 
SESSION 48 SCHEDULE
Thursday
SESSION 48: NEW DEVELOPMENTS IN AAAs AND EVAR
x
6:45 AM - 6:50 AM Thick Layer Of Thrombus In The Aortic Neck Should Not Be A Contraindication To EVAR: How To Size Neck Diameter With Thrombus: The Thrombus Resorbs With Time
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Abstract      
6:51 AM - 6:56 AM How Does Aortic Neck Morphology And Thrombus Burden Influence AAA Sac Behavior After EVAR
  Presenter(s):Thomas S. Maldonado, MD  
  View Abstract      
6:57 AM - 7:02 AM How Does Treatment Delay Increase The Risk Of AAA Repair With Open Surgery: With EVAR
  Presenter(s):Mahmoud B. Malas, MD, MHS  
  View Abstract      
7:03 AM - 7:08 AM What Is The Post EVAR Syndrome: How Should It Be Treated
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Abstract      
7:09 AM - 7:14 AM Preoperative Prednisone Enhances Recovery After EVAR In A RCT: What Is The Mechanism And Optimal Dosage
  Presenter(s):Torben V. Schroeder, MD, DMSc / Lars B. Lonn, MD, PhD  
  View Abstract      
7:15 AM - 7:20 AM DEBATE: Small AAAs (4.0-5.4 cm) Should Not Be Fixed
  Presenter(s):Frank A. Lederle, MD  
  View Abstract      
7:21 AM - 7:26 AM DEBATE: Despite The Level I Evidence, Many Small AAAs (4.0-5.4 cm) Should Be Fixed
  Presenter(s):William D. Jordan, Jr., MD  
  View Abstract      
7:27 AM - 7:32 AM Causes And Consequences Of Delay In Treatment Of AAAs And Why Unfit Patients With Large AAAs Should Be Treated: Without Treatment They Die Of Rupture: With Treatment They Can Survive
  Presenter(s):Katariina M. Noronen, MD / Maarit Venermo, MD / Mauri J.A. Lepantalo, MD  
  View Abstract      
7:33 AM - 7:38 AM In Women, Indexing AAA Diameter To Body Surface Area Is A Better Predictor Of Rupture Than Diameter Alone: Not So In Men: Why And What Are The Implications
  Presenter(s):Marc L. Schermerhorn, MD  
  View Abstract      
7:39 AM - 7:44 AM How Often Is Fenestrated EVAR Indicated In Today’s EVAR Population And Can It Be Done Safely By Percutaneous Access
  Presenter(s):Carlos H. Timaran, MD  
  View Abstract      
7:45 AM - 7:54 AM Panel Discussion
END OF SESSION 48
 
SESSION 49 SCHEDULE
Thursday
SESSION 49: NEW DEVELOPMENTS IN THE TREATMENT OF LESIONS OF THE AORTIC RANCHES AND THE VISCERAL SEGMENT OF THE AORTA
x
RENAL ARTERY LESIONS
7:54 AM - 7:59 AM What Is The Role Of Renal Artery Stenting After The CORAL And ASTRAL Trials
  Presenter(s):Thomas A. Sos, MD  
  View Abstract      
8:00 AM - 8:05 AM How Can We Predict The Success Of Renal Artery Stenting: It Is Not Just Looking At An Arteriogram
  Presenter(s):Monika L. Gloviczki, MD, PhD  
  View Abstract      
8:06 AM - 8:11 AM Endovascular Treatment Of Renovascular Disease In Pediatric Patients Is Dangerous And Ineffective
  Presenter(s):James C. Stanley, MD  
  View Abstract      
8:12 AM - 8:17 AM What Is The Current Data On The Natural History Of Renal Artery Aneurysms: How Should Traditional Treatment Criteria Be Changed
  Presenter(s):Peter F. Lawrence, MD  
  View Abstract      
8:18 AM - 8:23 AM Optimal Techniques For Endovascular Treatment Of Renal And Visceral Artery Aneurysms: Is Open Surgery Ever Best
  Presenter(s):Barry T. Katzen, MD  
  View Abstract      
8:24 AM - 8:29 AM Panel Discussion
MESENTERIC ARTERIES
Moderator(s): Edward Y. Woo, MD / Gustavo S. Oderich, MD, FACS  
8:30 AM - 8:35 AM DEBATE: Chronic Mesenteric Ischemia Is Best Treated Endovascularly
  Presenter(s):Craig M. Walker, MD  
  View Abstract      
8:36 AM - 8:41 AM DEBATE: Not So; Chronic Mesenteric Ischemia Is Best Treated By Open Surgery
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
8:42 AM - 8:47 AM Are Improved Early And Mid-Term Results With Covered Stents For Chronic Mesenteric Ischemia Durable: Technical Tips To Place Them
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Abstract      
8:48 AM - 8:53 AM Endovascular Treatment Of All 3 Mesenteric Arteries (CA, SMA, IMA): When Is It Necessary And Technical Tips
  Presenter(s):Furuzan Numan, MD  
  View Abstract      
VISCERAL SEGMENT OF AORTA
8:54 AM - 8:59 AM Middle Aortic Syndrome: When Is Treatment Indicated; When Not: Is PTA Ever Of Value
  Presenter(s):William J. Quinones-Baldrich, MD  
  View Abstract      
9:00 AM - 9:05 AM Endovascular Treatment Of Penetrating Ulcers Of The Aorta In The Infrarenal Segment; In The Visceral Segment
  Presenter(s):Afshin Assadian, MD  
  View Abstract      
9:06 AM - 9:11 AM Endovascular Treatment Of Isolated Abdominal Aortic Dissections: When Is It Necessary And How To Do It
  Presenter(s):Konstantinos P. Donas, MD / Giovanni Torsello, MD  
  View Abstract      
9:12 AM - 9:20 AM Panel Discussion
9:20 AM - 9:30 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 49
 
SESSION 50 SCHEDULE
Thursday
SESSION 50: NEW DEVELOPMENTS IN LAPAROSCOPIC VASCULAR SURGERY, PRESERVATION OF OPEN SURGICAL SKILLS, AND THE NATURAL HISTORY OF AAAs WITHOUT TREATMENT AND AFTER EVAR
x
LAPAROSCOPIC VASCULAR SURGERY
9:30 AM - 9:35 AM Decline Of Laparoscopic And Robotic Vascular Surgery: Will The Trend Be Reversed
  Presenter(s):Willem Wisselink, MD  
  View Abstract      
9:36 AM - 9:41 AM Short And Long-Term Results Of Laparoscopic Vascular Surgery: Will It Survive In The Endovascular Era
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
  View Abstract      
9:42 AM - 9:47 AM Why Laparoscopic Surgery For Aorto-Iliac Occlusive Disease Still Has A Future
  Presenter(s):Bernard J. Segers, MD  
  View Abstract      
AAA NATURAL HISTORY WITH AND WITHOUT TREATMENT
9:48 AM - 9:53 AM EVAR 1, DREAM, ACE And OVER Trials Show That Secondary Aortic Sac Rupture After EVAR Remains A Problem
  Presenter(s):Roger M. Greenhalgh, MD  
  View Abstract      
9:54 AM - 9:59 AM The Incidence Of AAAs Is Decreasing: Why Is This So And What Does It Mean For Screening
  Presenter(s):Frank A. Lederle, MD  
  View Abstract      
10:00 AM - 10:05 AM Better Long-Term Durability Results Can Be Achieved With EVAR Than In The EVAR, DREAM Or OVER Trials: Based On The Use Of A Third Generation Endograft Used In >200,000 Patients
  Presenter(s):Scott L. Stevens, MD  
  View Abstract      
10:06 AM - 10:11 AM Long-Term Results With EVAR Beyond 5 Years: Why Are They Better Than In The 3 Landmark EVAR vs. Open Repair RCTs (EVAR 1, DREAM AND OVER)
  Presenter(s):Timur P. Sarac, MD  
  View Abstract      
10:12 AM - 10:17 AM Why Should All High Risk AAAs Be Treated In A High Volume Center: Will It Happen
  Presenter(s):Mahmoud B. Malas, MD, MHS  
  View Abstract      
10:18 AM - 10:24 AM Panel Discussion
END OF SESSION 50
 
SESSION 51 SCHEDULE
Thursday
SESSION 51: HOT TOPICS IN THE TREATMENT OF JUXTARENAL AND PARARENAL AAAs, TAAAs AND RAAAs
x
10:24 AM - 10:29 AM Comparison Of FEVAR And Open Surgery For Juxtarenal AAAs: Why Open Surgery Is Still An Important Option
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Abstract      
10:30 AM - 10:35 AM DEBATE: Fenestrated EVAR (FEVAR) Is A Better Option Than Open Repair For Most Juxtarenal AAAs
  Presenter(s):Matthew J. Eagleton, MD  
  View Abstract      
10:36 AM - 10:41 AM DEBATE: Open Repair Is Better Than FEVAR For Most Juxtarenal AAAs
  Presenter(s):Richard G.J. Gibbs, FRCS / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
10:42 AM - 10:47 AM FEVAR Is The Treatment Of Choice For Pararenal And Paravisceral AAAs In Patients >80 Years Of Age: Based On A NSQIP Study
  Presenter(s):Anton N. Sidawy, MD, MPH  
  View Abstract      
10:48 AM - 10:53 AM G-I Complications From FEVAR Procedures Involving The Celiac And Superior Mesenteric Arteries: Causes And Prevention: Dangers Of CO2 Arteriography
  Presenter(s):Krassi Ivancev, MD, PhD  
  View Abstract      
10:54 AM - 10:59 AM DEBATE: For Juxta And Pararenal AAAs Off-The-Shelf Devices Are Best For Most Patients
  Presenter(s):Mark A. Farber, MD  
  View Abstract      
11:00 AM - 11:05 AM DEBATE: For Juxta And Pararenal AAAs Custom-Made Fenestrated Branched Endografts Are Best For Most Patients
  Presenter(s):Martin Malina, MD, PhD  
  View Abstract      
11:06 AM - 11:11 AM DEBATE: For Juxta And Pararenal AAAs Standard Endovascular Devices With Parallel Graft Adjuncts Are Best For Most Patients
  Presenter(s):Jason T. Lee, MD  
  View Abstract      
11:12 AM - 11:17 AM DEBATE: For Juxta And Pararenal AAAs All Types Of Endografts Are Necessary To Treat Patients Well
  Presenter(s):Giovanni Torsello, MD  
  View Abstract      
11:18 AM - 11:24 AM Panel Discussion
Moderator(s): Mark A. Farber, MD / Martin Malina, MD, PhD  
11:24 AM - 11:29 AM There Is Still A Place For AUI Endografts For Complex AAAs (Including Juxta And Pararenal) Although Parallel Graft And Adjuncts May Be Required
  Presenter(s):Martin R. Back, MD  
  View Abstract      
11:30 AM - 11:35 AM Outcomes Of Ruptured AAAs (Both Endo And Open) Are Better If Treated By Vascular Surgeons Than If Treated By General Surgeons: A NSQIP Study
  Presenter(s):Amy B. Reed, MD  
  View Abstract      
11:36 AM - 11:41 AM How Accurate Is The Diagnosis Of Rupture In AAA Patients Dying Without Treatment: An Important Parameter In Evaluating Natural History Studies
  Presenter(s):Katariina M. Noronen, MD / Maarit Venermo, MD / Mauri J.A. Lepantalo, MD  
  View Abstract      
11:42 AM - 11:47 AM For Short Necked Juxtarenal AAA What Is The Best Treatment: Standard EVAR, FEVAR, Standard EVAR With Chimneys Or Open Repair: What Is The Current Role Of Open Repair
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
  View Abstract      
11:48 AM - 11:53 AM Anatomic Scoring As A Predictor For The Outcome Of FEVAR For Juxtarenal AAA Repairs: How Useful Is It
  Presenter(s):Krassi Ivancev, MD, PhD  
  View Abstract      
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 51
 
SESSION 52 SCHEDULE
Thursday
SESSION 52: SOME ISSUES WITH MALPRACTICE, OFF-LABEL USE, OUTPATIENT PRACTICE, CENTRALIZATION AND TRAINING, UPDATES
x
1:00 PM - 1:05 PM In A Malpractice Case, How Can One Resolve A Problem With A Bad Or Biased Expert Witness Or An Interventional Expert Who Considers Any Open Procedure With A Poor Result Malpractice
  Presenter(s):O. William Brown, MD, JD  
  View Abstract      
1:06 PM - 1:11 PM DEBATE: Should We Treat Patients Outside IFUs: Yes, There Are Real Benefits And Upsides
  Presenter(s):Jason T. Lee, MD  
  View Abstract      
1:12 PM - 1:17 PM DEBATE: Should We Treat Patients Outside IFUs: No, There Are Many Downsides And Risks Including Malpractice
  Presenter(s):O. William Brown, MD, JD  
  View Abstract      
OUTPATIENT ISSUES
1:18 PM - 1:23 PM Tips And Tricks For Use Of CO2 Arteriography And Venography In An Outpatient Facility: Advantages And Limitations
  Presenter(s):Kyung Cho, MD  
  View Abstract      
1:24 PM - 1:29 PM High Quality Digital Fluoroscopy With A Motorized C-Arm Can Facilitate Complex Endovascular Procedures In An Outpatient Setting
  Presenter(s):Enrico Ascher, MD  
  View Abstract      
1:30 PM - 1:35 PM Outpatient Fast Track EVAR: When Is It Feasible And Safe And Tips On How To Do It: Advantages And Risks
  Presenter(s):Zvonimir Krajcer, MD, FACC  
  View Abstract      
TRAINING ISSUES
1:36 PM - 1:41 PM Operator Training For Fenestrated Devices: Is The Technique Broadly Applicable
  Presenter(s):Luis A. Sanchez, MD  
  View Abstract      
1:42 PM - 1:47 PM How To Retrain And Train In The Open Surgical Skills That Vascular Surgeons Will Need In The Future
  Presenter(s):James May, MD, MS, FRACS, FACS  
  View Abstract      
1:48 PM - 1:54 PM Panel Discussion
END OF SESSION 52
 
SESSION 53 SCHEDULE
Thursday
SESSION 53: NEW TECHNOLOGIES, TECHNIQUES, UPDATES AND MORE ON MLFM STENTS
x
1:54 PM - 1:59 PM Value And Technique For Aortic Balloon Control In Vascular Trauma Patients
  Presenter(s):George H. Meier III, MD  
  View Abstract      
2:00 PM - 2:05 PM Almost All Aorto-Iliac Occlusions Can Be Treated Endovascularly: Tips And Tricks For Doing So Safely
  Presenter(s):Zvonimir Krajcer, MD, FACC  
  View Abstract      
2:06 PM - 2:11 PM Outcomes Of Percutaneous EVAR: When Is It Contraindicated: Tips And Tricks For Doing It Safely
  Presenter(s):Ali F. AbuRahma, MD  
  View Abstract      
2:12 PM - 2:17 PM Advantages Of Microbubbles To Reduce Dose Of Thrombolytics For Clot Lysis: Bleeding Risk Is Decreased: How Does It Work
  Presenter(s):Kak Khee Yeung, MD, PhD / Willem Wisselink, MD  
  View Abstract      
2:18 PM - 2:23 PM New Approaches To Developing Better Arterial Grafts
  Presenter(s):George Hamilton, MD; FRCS  
  View Abstract      
2:24 PM - 2:29 PM US Population Based Survey Shows Surveillance After EVAR Falls Short In >50% Of Patients: What Can And Should Be Done About It
  Presenter(s):Andres Schanzer, MD  
  View Abstract      
MORE ABOUT MLFM STENTS
2:30 PM - 2:35 PM Moroccan Results Of The MLFM Stent Experience For Treating Complex Aortic Aneurysms And Type B Dissections
  Presenter(s):Amira Benjelloun, MD  
  View Abstract      
2:36 PM - 2:41 PM How The MLFM Bare Stent Can Change The Natural History And Behavior Of Aortic Aneurysms: Theoretical Considerations
  Presenter(s):Mark F. Fillinger, MD  
  View Abstract      
2:42 PM - 2:47 PM The Phantom MLFM Aorto Bi-Iliac Device: A Fresh Perspective On The Treatment Of Aortic And Iliac Aneurysms
  Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC  
  View Abstract      
2:48 PM - 2:56 PM Panel Discussion
2:56 PM - 3:06 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 53
 
SESSION 54 SCHEDULE
Thursday
SESSION 54: OPEN SURGERY AND AORTIC COARCTATION RELATED TOPICS
x
3:06 PM - 3:11 PM The Value Of Open Surgery Simulators In Training Of Vascular Surgeons: How Do They Work And Can They Help
  Presenter(s):Afshin Assadian, MD  
  View Abstract      
3:12 PM - 3:17 PM Is There A Role For Open Surgical Treatment Of Renal Artery Stenosis For Renovascular Hypertension After The ASTRAL And CORAL Trials
  Presenter(s):George Hamilton, MD; FRCS  
  View Abstract      
3:18 PM - 3:23 PM Why Is Axillo-Bifemoral Bypass The New Gold Standard – Replacing Aorto-Bifemoral Bypass When Open Surgery Is Required For Aorto-Iliac Occlusive Disease: What Are The Current Indications For Not Using Endovascular Treatments
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Abstract      
3:24 PM - 3:29 PM 10-Year Results Of Open Repair Of Juxtarenal AAAs: How Durable Is The Procedure And Is It A Better Treatment Than FEVAR Or Chimney Grafts With EVAR
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Abstract      
3:30 PM - 3:35 PM How To Perform Open Conversion Safely After Failed EVAR: Tips And Tricks
  Presenter(s):Dieter Raithel, MD, PhD  
  View Abstract      
3:36 PM - 3:41 PM When Is Open Surgical Repair Of AAAs Indicated In The Endovascular Era: In What Percentage Of Cases Will It Be Necessary
  Presenter(s):Edward Y. Woo, MD  
  View Abstract      
3:42 PM - 3:47 PM When Is Open Surgical Repair Required And The Best Treatment For Complex Vascular Injuries In The Endovascular Era
  Presenter(s):Samy S. Nitecki, MD  
  View Abstract      
3:48 PM - 3:53 PM How To Make Carotid Body Tumor Excision Almost Bloodless
  Presenter(s):Francesco Spinelli, MD  
  View Abstract      
AORTIC COARCTATION TOPICS
3:54 PM - 3:59 PM DEBATE: Covered Balloon Expandable Stents (Advanta V12) Are The Best And Most Durable Way To Treat Aortic Coarctations: When Are They Not
  Presenter(s):Elchanan Bruckheimer, MBBS  
  View Abstract      
4:00 PM - 4:05 PM DEBATE: Bare Metal Balloon Expandable Stents Are The Best Most Durable Way To Treat Most Aortic Coarctations: When Are They Not
  Presenter(s):Christoph A. Nienaber, MD, PhD  
  View Abstract      
4:06 PM - 4:11 PM Endovascular Treatment Of Late Complications (Recurrent Stenosis And/Or Aneurysm) Of Surgically Repaired Aortic Coarctations
  Presenter(s):William J. Quinones-Baldrich, MD  
  View Abstract      
4:12 PM - 4:19 PM Panel Discussion
END OF SESSION 54
 
SESSION 55 SCHEDULE
Thursday
SESSION 55: VISCERAL, RENAL AND HYPOGASTRIC ARTERY ISSUES
x
MESENTERIC ISCHEMIA
4:19 PM - 4:24 PM Endovascular Treatment Of Acute Mesenteric Ischemia: Value Of First Look Laparoscopy Or Laparotomy
  Presenter(s):Joseph S. Giglia, MD / George H. Meier III, MD  
  View Abstract      
4:25 PM - 4:30 PM Treatment Of Isolated SMA Dissection Producing Acute Mesenteric Ischemia
  Presenter(s):Robert B. McLafferty, MD  
  View Abstract      
VISCERAL ARTERY ANEURYSMS
4:31 PM - 4:36 PM Endovascular Treatment Of Celiac Artery Branch Pseudoaneurysms With Life Threatening Hemorrhage: When To Use Covered Stents; When To Use Coil Embolization; Is Open Surgery Ever The Best Treatment
  Presenter(s):Kyung Cho, MD  
  View Abstract      
4:37 PM - 4:42 PM When Is Endovascular Repair Indicated With Ruptured Visceral Artery Aneurysms: What Are The Outcomes Of Endovascular And Open Treatments
  Presenter(s):Rabih A. Chaer, MD  
  View Abstract      
4:43 PM - 4:48 PM Inferior Pancreatico-Duodenal Artery Aneurysms Are Commonly Associated With Celiac Artery Occlusions: What Is The Best Option For Treatment
  Presenter(s):Ronald M. Fairman, MD  
  View Abstract      
4:49 PM - 4:54 PM Should All Splenic Artery Aneurysms Be Managed Endovascularly: When Should They Not Be
  Presenter(s):Bauer E. Sumpio, MD, PhD  
  View Abstract      
RENAL ARTERY ANEURYSMS
4:55 PM - 5:00 PM Natural History Of Renal Artery Aneurysms: Which Treatment (Endo vs. Open) Option Is Best And When
  Presenter(s):Neal S. Cayne, MD  
  View Abstract      
5:01 PM - 5:06 PM Coiling vs. Covered Stenting For Renal Artery Aneurysms: When Is Open Surgery The Best Treatment
  Presenter(s):Furuzan Numan, MD  
  View Abstract      
HYPOGASTRIC ARTERY AND LONG-TERM FEVAR TOPICS
5:07 PM - 5:12 PM How Should Isolated Iliac Artery Aneurysms Be Treated: Management Of The Hypogastric Especially When It Is Aneurysmal
  Presenter(s):Lars B. Lonn, MD, PhD  
  View Abstract      
5:13 PM - 5:18 PM Hypogastric Artery Revascularization With EVAR: When Is Coil Or Occluder Use Acceptable: Which Branch Device Is Best: What About Sandwich Grafts
  Presenter(s):Piergiorgio Cao, MD, FRCS / Fabio Verzini, MD, PhD  
  View Abstract      
5:19 PM - 5:24 PM Clinical Trial Results With The Gore Branched Device For Hypogastric Revascularization: Are There Limitations
  Presenter(s):Darren B. Schneider, MD  
  View Abstract      
5:25 PM - 5:30 PM Hypogastric Artery Revascularization During EVAR Using 2 Commercially Available Devices (Gore C3 And Endologix AFX) Without Need For Brachial Access: How To Do It
  Presenter(s):Brian G. DeRubertis, MD  
  View Abstract      
5:31 PM - 5:36 PM 10-Year Experience With Iliac Branched Devices (IBDs) For Hypogastric Artery Revascularization During EVAR: Durability And Pitfalls To Avoid
  Presenter(s):Martin J. Austermann, MD / Konstantinos P. Donas, MD / Giovanni Torsello, MD  
  View Abstract      
5:37 PM - 5:42 PM 14-Year Experience With FEVAR: The Procedure Is Durable But Reinterventions May Be Required
  Presenter(s):Michael J. Denton, FRACS / Domenic Robinson, MD  
  View Abstract      
5:43 PM - 5:48 PM Different Techniques To Preserve The Hypogastric Arteries During EVAR: Tips And Tricks
  Presenter(s):Claudio J. Schonholz, MD  
  View Abstract      
5:49 PM - 5:57 PM Panel Discussion

End of Program G

END OF SESSION 55
 
SESSION 56 SCHEDULE
Thursday
SESSION 56: NEW AND UPDATED ENDOVASCULAR GRAFTS AND DEVICES FOR USE IN ABDOMINAL AORTIC DISEASE
x
6:45 AM - 6:50 AM Are The Outcomes And Costs Different With Current Endovascular Graft Systems For EVAR: Based On Data From The OVER Trial
  Presenter(s):Jon S. Matsumura, MD  
  View Abstract      
6:51 AM - 6:56 AM Next Generation Endografts For AAAs: Are They Iterative Or Transformative
  Presenter(s):Robert M. Bersin, MD  
  View Abstract      
6:57 AM - 7:02 AM Trouble In Paradise: How EVAR Advances And Pushing The Endo Envelope Can Lead To Disaster And Harm Patients
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Abstract      
7:03 AM - 7:08 AM A Better Gore Excluder C3 Device That Is Not Only Repositionable But Also Has A Modifiable Body Angle That Can Adapt The Proximal Fixation And Sealing Zone With Difficult AAA Neck Anatomy
  Presenter(s):Dittmar Boeckler, MD  
  View Abstract      
7:09 AM - 7:14 AM World Experience With The Bolton Treovance Device For EVAR: The RATIONALE Registry: What Are The Device’s Advantages And Results
  Presenter(s):Vicente Riambau, MD, PhD  
  View Abstract      
7:15 AM - 7:20 AM Use Of The Anaconda Fenestrated Endograft For EVAR In Challenging Or Hostile Anatomy: Advantages And Results
  Presenter(s):Nick J. Burfitt, BSc, MB, BChir, MRCS, FRCR / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Abstract      
7:21 AM - 7:26 AM How Well Does The Vascutek Anaconda Fenestrated Cuff Work To Treat Complications Of Standard EVAR: Advantages And Experience To Date
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS / Nick J. Burfitt, BSc, MB, BChir, MRCS, FRCR  
  View Abstract      
7:27 AM - 7:32 AM Results With The Nellix Device For Endovascular AAA Sealing (EVAS) In Europe: Advantages And Tips To Avoid Complications
  Presenter(s):Dittmar Boeckler, MD  
  View Abstract      
7:33 AM - 7:38 AM The NELLIX EVAS FORWARD Global Registry: Early Results In 250 Patients: Nellix (EVAS) Device To Treat AAAs With Adverse Features: What Has Been The Need For Reinterventions And How Is It Better Than Conventional EVAR Devices
  Presenter(s):Andrew Holden, MBChB  
  View Abstract      
7:39 AM - 7:44 AM Experience With The Nellix Device For AAAs: When Should It Be Used Preferentially And Can It Be Used To Treat Complications Of Other AAA Repairs Like Endoleaks, Anastomotic Breakdown And Ruptures
  Presenter(s):Ian Loftus, MD / Matt M. Thompson, MD  
  View Abstract      
7:45 AM - 7:49 AM Expanding The Applicability Of EVAR Safely With The TriVascular Ovation Device
  Presenter(s):Sean P. Lyden, MD  
  View Abstract      
7:50 AM - 7:58 AM Panel Discussion
END OF SESSION 56
 
SESSION 57 SCHEDULE
Thursday
SESSION 57: MORE ABOUT NEW AND UPDATED ENDOVASCULAR GRAFTS, DEVICES AND TECHNOLOGIES FOR TREATING ABDOMINAL AORTIC DISEASE,COMPLEX AAAs AND INFECTIONS
x
7:58 AM - 8:03 AM 2-Year Results With The Ovation Graft From TriVascular For EVAR: Advantages Of This Low Profile Device
  Presenter(s):Dierk Scheinert, MD  
  View Abstract      
8:04 AM - 8:09 AM How To Maximize The Benefits Of The Sealing Zone In The Ovation Endograft: Tips And Tricks
  Presenter(s):David J. Minion, MD  
  View Abstract      
8:10 AM - 8:15 AM The Altura Endograft For EVAR: Advantages And 2-Year Results
  Presenter(s):Albrecht H. Kramer, MD  
  View Abstract      
8:16 AM - 8:21 AM 3-Year European Results With A Lower Profile Device For EVAR: Advantages Of The Incraft From Cordis: The INNOVATION Trial
  Presenter(s):Giovanni Pratesi, MD / Giovanni Torsello, MD  
  View Abstract      
8:22 AM - 8:27 AM US Experience With The New Cordis Incraft For EVAR: Advantages And Limitations
  Presenter(s):Michel Makaroun, MD  
  View Abstract      
8:28 AM - 8:33 AM Results With The Aorfix EVAR Device From Lombard Are Good: How Iliac Morphology And Changes In Morphology Affect Outcomes
  Presenter(s):Brian R. Hopkinson, ChM, FRCS  
  View Abstract      
8:34 AM - 8:39 AM Good Mid-Term Outcomes With The Aorfix Endograft In The PYTHAGORAS PMA Trial: Advantages And Limitations
  Presenter(s):Mark F. Fillinger, MD  
  View Abstract      
8:40 AM - 8:45 AM When Is A Chimney Graft Procedure Better Than A Fenestrated Graft: How To Design A Better Aortic Endograft To Conform To Chimney Or Other Parallel Grafts
  Presenter(s):Claude Mialhe, MD  
  View Abstract      
8:46 AM - 8:51 AM Update On The Ventana Fenestrated Graft From Endologix: What Are Its Advantages And What Is Its Current Status
  Presenter(s):Daniel G. Clair, MD  
  View Abstract      
8:52 AM - 8:57 AM Results With A New Concept And Endograft For EVAR And TEVAR: The Horizon Endograft: The Concept Can Be Used To Construct Branched Grafts In Any Location
  Presenter(s):Gioachino Coppi, MD  
  View Abstract      
8:58 AM - 9:03 AM How Does The Endologix AFX Endograft Achieve A Seal In Irregular AAA Necks: Why Is It Better Than Other Aortic Endografts: Proof On A Dynamic CT Scan
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Abstract      
9:04 AM - 9:09 AM Advantages Of The Vela AFX Endograft System From Endologix: How Does It Make EVAR Better Or Easier – Particularly With Challenging AAA Necks
  Presenter(s):Julio A. Rodriguez-Lopez, MD  
  View Abstract      
9:10 AM - 9:15 AM 1-Year Results With A New Iliac Side Branched Device From Jotec For Revascularizing Hypogasric Arteries: Advantages And Limitations
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Abstract      
9:16 AM - 9:21 AM Updated Experience With Treatment Of Infected Aortic Grafts Using A Neo-Aorta Constructed With Spiral Greater Saphenous Vein: Why Is It Better Than Using Deep Lower Extremity Veins Or Other Techniques
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
  View Abstract      
9:22 AM - 9:29 AM Panel Discussion
9:29 AM - 9:40 AM Break - Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 57
 
SESSION 58 SCHEDULE
Thursday
SESSION 58: NEW OR IMPROVED ENDOGRAFTS, DEVICES, TECHNOLOGIES AND INFORMATION FOR TREATING THORACIC AORTIC DISEASE AND COMPLEX ANEURYSMS
x
9:40 AM - 9:45 AM In The UK Does TEVAR For Descending Thoracic Aortic Aneurysms Win Over Open Repair And Should We Be Looking For Asymptomatic Thoracic Aneurysms
  Presenter(s):Janet T. Powell, MD, PhD  
  View Abstract      
9:46 AM - 9:51 AM IVUS Is A Necessary Adjunctive Technology For Adequate TEVAR Treatment Of Complicated TBADs
  Presenter(s):Ali Azizzadeh, MD  
  View Abstract      
9:52 AM - 9:57 AM Early Experience With Newer Lower Profile Zenith Alpha Endografts For TEVAR And EVAR From Cook: How Well Do They Work
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Abstract      
9:58 AM - 10:03 AM Conformability Matters With TEVAR In Or Near The Aortic Arch: Modifications Of The C-TAG Device To Deal With Radial Fit Issues Of The Proximal Endograft: Redeployability And The Ability To Modify Proximal Graft Angles Are Also Helpful
  Presenter(s):Alan B. Lumsden, MD, FACS  
  View Abstract      
10:04 AM - 10:09 AM Early Results With A New Off-The-Shelf Branched Gore Endograft For TAAA Repairs: Advantages And Limitations
  Presenter(s):Pierre Galvagni Silveira, MD, PhD  
  View Abstract      
10:10 AM - 10:15 AM The GREAT Registry Confirms That The Gore Conformable C-TAG Endograft Is Working Well Near The Aortic Arch
  Presenter(s):Fred A. Weaver, MD  
  View Abstract      
10:16 AM - 10:21 AM A Modified Relay Endograft With A Proximal Scalloped Or Fenestrated Opening (From Bolton) To Preserve Left Subclavian Flow: A Branched Graft Is Unnecessary: How Well Does This Bolton Graft Work
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Abstract      
10:22 AM - 10:27 AM Advantages, Limitations And Early Results With The JOTEC Device For F/B EVAR Repair Of TAAAs And Iliac Aneurysms
  Presenter(s):Burkhart Zipfel, MD, PhD  
  View Abstract      
10:28 AM - 10:33 AM Another Novel Potentially Off-The-Shelf Modular Branched Endovascular Graft From JOTEC For TAAAs: The Way It Works And Early Clinical Experience
  Presenter(s):Mario Lachat, MD / Giovanni Torsello, MD / Nicola Mangialardi, MD  
  View Abstract      
10:34 AM - 10:44 AM Panel Discussion
END OF SESSION 58
 
SESSION 59 SCHEDULE
Thursday
SESSION 59: MORE NEW OR IMPROVED ENDOGRAFTS, DEVICES, TECHNOLOGIES AND INFORMATION FOR TREATING THORACIC AORTIC DISEASE AND COMPLEX ANEURYSMS
x
10:44 AM - 10:49 AM The Left Subclavian Artery (LSA) Can Be Covered In Most TEVAR Cases Without Revascularization: When Is Revascularization Necessary: Based On Data From The C-TAG Trial And The GREAT Registry
  Presenter(s):Dittmar Boeckler, MD  
  View Abstract      
10:50 AM - 10:55 AM LSA Origin Coverage During TEVAR Is Safe And Can Be Performed Without Complications Except In Specific Circumstances: What Are They
  Presenter(s):Gustav Fraedrich, MD  
  View Abstract      
10:56 AM - 11:01 AM LSA Flow Should Be Maintained During TEVAR: This Can Be Achieved With A Novel New Branched Device: The MONA LSA Device From Medtronic: How Does It Work And Early Results
  Presenter(s):Frank R. Arko, MD  
  View Abstract      
11:02 AM - 11:07 AM Clinical Experience With The MONA LSA Branched Device From Medtronic To Revascularize The Left Subclavian Artery During TEVAR
  Presenter(s):Eric E. Roselli, MD  
  View Abstract      
11:08 AM - 11:13 AM A Single Branched Endograft For TEVAR With Subclavian Revascularization From Gore: How Does It Work And Early Results: It Can Be Used To Treat All Arch Lesions Without Thoracotomy
  Presenter(s):Michael D. Dake, MD  
  View Abstract      
11:14 AM - 11:19 AM Laser Fenestration For LSA Revascularization During TEVAR: Technique And 4-Year CT Documented Durability
  Presenter(s):Jean M. Panneton, MD  
  View Abstract      
11:20 AM - 11:25 AM Advantages And Mid-Term Results With The Bolton Relay Endograft For TEVAR Extending Into Or Near The Arch
  Presenter(s):Vicente Riambau, MD, PhD  
  View Abstract      
11:26 AM - 11:31 AM Why Low Profile Devices Are Important For TEVAR: They Are Available With The Cook Zenith Alpha System
  Presenter(s):Giovanni Torsello, MD  
  View Abstract      
11:32 AM - 11:37 AM A New Low Profile Endovascular Device From Cook To Treat Traumatic Aortic Injuries In Young Patients: Advantages And Limitations
  Presenter(s):Benjamin W. Starnes, MD  
  View Abstract      
11:38 AM - 11:43 AM Advantages Of New Zenith Alpha System For TEVAR And EVAR: Are There Limitations
  Presenter(s):Timothy A. Resch, MD, PhD  
  View Abstract      
11:44 AM - 11:49 AM New Endografts From Gore For F/B EVAR: Concepts For Easier Treatment Of Juxta, Para And Thoracoabdominal Aortic Aneurysm Repairs
  Presenter(s):Wayne W. Zhang, MD  
  View Abstract      
11:50 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 59
 
SESSION 60 SCHEDULE
Thursday
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES AND TECHNIQUES, STENTS, BIOABSORBABLE STENTS AND STENT-GRAFTS FOR TREATING LOWER EXTREMITY DISEASE AND ISCHEMIA
x
1:00 PM - 1:05 PM 3-Year Results Of The STROLL Trial With Smart Stents In The SFA: Patency And Quality Of Life Are Maintained
  Presenter(s):Michael R. Jaff, DO  
  View Abstract      
1:06 PM - 1:11 PM What Will Be the Standard Of Care for Treating Primary Lesions In The SFA And Below: Update On The BIOLUX P-I And BIOLUX P-II Trial Results
  Presenter(s):Patrick Peeters, MD / Thomas Zeller, MD  
  View Abstract      
1:12 PM - 1:17 PM Unique Properties Of A New Dual Component (Nitinol And PTFE) Stent: The Gore Tigris Conformable Stent: Early Results And When Should It Be Used
  Presenter(s):John R. Laird, MD  
  View Abstract      
1:18 PM - 1:23 PM An Improved Helical 3D Stent (The Biomimics Stent) May Resist Kinking, Lead To Swirling Blood Flow, Decreased ISR And Improved Patency At 2 Years
  Presenter(s):Thomas Zeller, MD  
  View Abstract      
BIOABSORBABLE STENTS
1:24 PM - 1:29 PM The Only Good Solution For Treatment Of Peripheral Artery Occlusive Lesions Must Avoid Permanent Implants: Bioabsorbable Scaffold Will Be The Future
  Presenter(s):Renu Virmani, MD  
  View Abstract      
1:30 PM - 1:35 PM A Bioabsorbable Vascular Scaffolding Stent With Drug Elution: The BVM Stent With Good 1-Year Results In The SFA: The ESPRIT Trial
  Presenter(s):Johannes Lammer, MD  
  View Abstract      
1:36 PM - 1:41 PM A Bioabsorbable Stent From Elixir Medical: How Does It Work And How Good Is It
  Presenter(s):Dierk Scheinert, MD  
  View Abstract      
1:42 PM - 1:47 PM Third Generation Bioabsorbable Self-Expanding DES Will Improve Results In Lower Extremity Occlusive Disease: Results With The Stanza DR Stent
  Presenter(s):Andrew Holden, MBChB  
  View Abstract      
1:48 PM - 1:53 PM Early And Mid-Term Results Of An Absorbable Stent For SFA Lesions
  Presenter(s):Gioachino Coppi, MD  
  View Abstract      
1:54 PM - 1:59 PM The Belgian REMEDY Registry Of Experience With The Bioabsorbable Remedy Stent In The SFA: 1-Year Results
  Presenter(s):Peter C.J. Goverde, MD  
  View Abstract      
STENT-GRAFTS
2:00 PM - 2:05 PM Endovascular Reconstruction Of Complex Aorto-Iliac Lesions: Stents vs. Covered Stents: Indications For Which And Why
  Presenter(s):B. Patrice Mwipatayi, FRACS  
  View Abstract      
2:06 PM - 2:11 PM Uses For The Gore Hybrid Partially Stented PTFE Graft To Facilitate Arterial Bypasses In Multiple Locations
  Presenter(s):Edward Y. Woo, MD  
  View Abstract      
2:12 PM - 2:20 PM Panel Discussion
END OF SESSION 60
 
SESSION 61 SCHEDULE
Thursday
SESSION 61: NEW AND IMPROVED TECHNIQUES, STENTS, STENT-GRAFTS AND PROSTHETIC (PTFE) VASCULAR GRAFTS FOR TREATING LOWER EXTREMITY DISEASE AND ISCHEMIA
x
2:20 PM - 2:25 PM How To Deal With Flush SFA Occlusions Endovascularly And Preserve Profunda Flow: Tips And Tricks
  Presenter(s):George H. Meier III, MD  
  View Abstract      
2:26 PM - 2:31 PM A New More Conformable Covered Stent From Gore: Advantages, Limitations And Clinical Results
  Presenter(s):Andrew Holden, MBChB  
  View Abstract      
IMPROVED PROSTHETIC VASCULAR GRAFTS
2:32 PM - 2:37 PM Is There A Role For Prosthetic Bypasses Below The Knee And To Tibial Arteries And How To Make Them Work
  Presenter(s):Richard F. Neville, MD  
  View Abstract      
2:38 PM - 2:43 PM PTFE Tibial And Peroneal Bypasses When Vein Is Unavailable: They Yield Better Results Than Generally Acknowledged: An Update Based On A 30-Year Experience
  Presenter(s):Gregg S. Landis, MD / Frank J. Veith, MD  
  View Abstract      
2:44 PM - 2:49 PM Status Of The Propaten Heparin Bonded PTFE Graft: How Do We Know That It Is Better Than Standard PTFE Grafts
  Presenter(s):Edward Y. Woo, MD  
  View Abstract      
2:50 PM - 2:55 PM Final 5-Year Results Of RCT Comparing Heparin Bonded PTFE (Propaten) Grafts vs. Standard PTFE Grafts In Fem-Pop And Fem-Fem Bypasses: How Durable Are The Benefits
  Presenter(s):Jes S. Lindholt, MD  
  View Abstract      
2:56 PM - 3:01 PM DEBATE: 5-Year Results With Heparin Bonded PTFE (Propaten) Grafts Are Better Than Standard PTFE And May Be As Good As ASV
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Abstract      
3:02 PM - 3:07 PM DEBATE: I Don’t Believe It: Good ASV Has To Be Better Than Any Prosthetic Graft
  Presenter(s):Michael S. Conte, MD  
  View Abstract      
3:08 PM - 3:13 PM When Are Prosthetic PTFE Grafts In The Lower Extremity As Good As Vein Grafts: Does Warfarin Help
  Presenter(s):Jack L. Cronenwett, MD  
  View Abstract      
3:14 PM - 3:19 PM PTFE Grafts With Heparin Bonding (Propaten) Can Have Good Patency Results Even When BK Popliteal And Crural Arteries Are Used For Outflow: Their Bad Reputation Is Undeserved
  Presenter(s):Walter Dorigo, MD  
  View Abstract      
3:20 PM - 3:25 PM Advantages Of The Fusion Bioline 2-Element Heparin Bonded PTFE Graft: Based On The FINEST Multicenter RCT
  Presenter(s):Alan B. Lumsden, MD, FACS  
  View Abstract      
3:26 PM - 3:40 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 61
 
SESSION 62 SCHEDULE
Thursday
SESSION 62: ADDITIONAL NEW INFORMATION RELATED TO LOWER EXTREMITY ISCHEMIA AND POPLITEAL ANEURYSM MANAGEMENT
x
3:40 PM - 3:45 PM Tips And Tricks To Make Endovascular Treatment Of Acute Limb Ischemia Effective 100% Of The Time: Are Open Procedures Ever Required
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Abstract      
3:46 PM - 3:51 PM Ultrasound Enhanced Thrombolysis (EKOS) For The Treatment Of Infrainguinal Arterial Thrombosis: The Duet I And II Trial
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Abstract      
3:52 PM - 3:57 PM In Dialysis Patients With CLI How Much Can Be Achieved With Endovascular Treatments: Is Open Bypass Ever Needed
  Presenter(s):Francesco Liistro, MD  
  View Abstract      
3:58 PM - 4:03 PM Lower Extremity Revascularization In Dialysis Patients With CLI: Is It Of Value: When Endo; When Open; When A Primary Amputation
  Presenter(s):Rabih A. Chaer, MD  
  View Abstract      
4:04 PM - 4:09 PM What Is The Importance Of Patency After PTA-Stenting Or Bypass For Intermittent Claudication; For CLI: What Is The Mechanism For Exercise Improvement With Intermittent Claudication
  Presenter(s):Iris Baumgartner, MD  
  View Abstract      
4:10 PM - 4:15 PM Endovascular Treatment Of Extensive Aorto-Iliac Occlusive Disease With A Bifurcated Endograft: A Potential Alternative To Kissing Stents Or Stent-Grafts
  Presenter(s):Thomas S. Maldonado, MD  
  View Abstract      
4:16 PM - 4:21 PM Evolving Treatment For Popliteal Aneurysms: When At Present Is Endovascular Treatment Contraindicated
  Presenter(s):Ali F. AbuRahma, MD  
  View Abstract      
4:22 PM - 4:27 PM Elective And Emergent Treatment Of Popliteal Aneurysms: Can They All Be Treated Endovascularly And How Often Is Open Repair Indicated
  Presenter(s):Joseph J. Ricotta II, MD, MS  
  View Abstract      
4:28 PM - 4:34 PM Panel Discussion
END OF SESSION 62
 
SESSION 63 SCHEDULE
Thursday
SESSION 63: NEW AND IMPROVED DEVICES FOR ENDOSTAPLING OR ENDOANCHORING FOR EVAR AND TEVAR
x
FOR AAA ENDOGRAFT PROCEDURES
4:34 PM - 4:39 PM Do Aptus Heli-Fx EndoAnchors Provide Long-Term (5 Years) Fixation Of Endografts In AAA Necks After EVAR: Do They Decrease The Need For Surveillance: Do They Fix Endoleaks: Are They Worth Their Cost
  Presenter(s):David H. Deaton, MD  
  View Abstract      
4:40 PM - 4:45 PM Can Heli-Fx EndoAnchors Resolve Type I Endoleaks And Improve Long-Term Endograft Fixation: In Short Necked AAAs Are They Equal Or Superior To FEVARs Or Chimneys: Based On The ANCHOR Registry
  Presenter(s):William D. Jordan, Jr., MD  
  View Abstract      
4:46 PM - 4:51 PM Mid-Term Results Of The Global And Dutch EndoAnchor Registries Of The Heli-Fx Endograft Stapling Devices: Can It Fix Type I Endoleaks And Graft Migration: Can It Be Proven
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Abstract      
4:52 PM - 4:57 PM Large Palmaz Stents vs. EndoAnchors To Fix Type I Endoleaks: Which Is Better And When
  Presenter(s):Dittmar Boeckler, MD  
  View Abstract      
4:58 PM - 5:03 PM Do EndoAnchors Improve Sac Regression After EVAR
  Presenter(s):Bart E. Muhs, MD, PhD  
  View Abstract      
5:04 PM - 5:09 PM Active Aortic Endograft Fixations With A Novel New Endostapling System By Vestech/Jotec: Description and Advantages
  Presenter(s):Thierry Richard, MD  
  View Abstract      
FOR THORACIC PROCEDURES
5:10 PM - 5:15 PM Value And Limitations Of Aptus Heli-Fx EndoAnchors In TEVAR Procedures: Can They Prevent Or Fix Type I Endoleaks From Difficult Neck Anatomy
  Presenter(s):Piotr M. Kasprzak, MD  
  View Abstract      
5:16 PM - 5:21 PM Can Delayed Type I Endoleaks After TEVAR Be Treated Successfully With Heli-Fx EndoAnchors
  Presenter(s):Manish Mehta, MD, MPH  
  View Abstract      
5:22 PM - 5:27 PM Value Of Heli-Fx EndoAnchors During Or After TEVAR Procedures
  Presenter(s):Jean M. Panneton, MD  
  View Abstract      
5:28 PM - 5:38 PM Panel Discussion

End of Program H

END OF SESSION 63
 
SESSION 64 SCHEDULE
Thursday
SESSION 64: VENOUS CLINICAL EXAMINATION AND SELECTING PATIENTS APPROPRIATELY
x
6:49 AM - 6:54 AM CEAP & VCSS: Establishing The Treatment Plan Based On Clinical Findings
  Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS  
  View Abstract      
6:55 AM - 7:00 AM What Duplex Ultrasound Mapping Adds To The Exam
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Abstract      
7:01 AM - 7:06 AM Quantifying Saphenous Reflux
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
7:07 AM - 7:12 AM Value Of A Diagnostic Score Ascribing Leg Symptoms To Chronic Venous Disorders In Patients Undergoing Surgery For Varicose Veins
  Presenter(s):Paul Pittaluga, MD  
  View Abstract      
7:13 AM - 7:18 AM What Do The Quality Measures (QM) Measure: A Critical Analysis Of PQRS (Physician Quality Reporting System) Measures For Venous Disease
  Presenter(s):Fedor Lurie, MD, PhD  
  View Abstract      
7:19 AM - 7:24 AM The LET Score As A Standardized DVT Classification
  Presenter(s):Cees H.A. Wittens, MD, PhD  
  View Abstract      
7:25 AM - 7:30 AM Hemodynamic Approach On Superficial Venous Reflux (ASVAL): Does It Work
  Presenter(s):Sylvain Chastanet, MD  
  View Abstract      
7:31 AM - 7:36 AM A New Look At Venous Hemodynamics: The Importance Of Measuring Both Reflux And Venous Ouflow Obstruction
  Presenter(s):Andrew N. Nicolaides, MS  
  View Abstract      
7:37 AM - 7:42 AM Hemodynamic Approach On Superficial Venous Reflux (CHIVA): Does It Work
  Presenter(s):Byung-Boong Lee, MD  
  View Abstract      
7:43 AM - 7:48 AM Why Is Individual Risk Assessment For Thrombosis Important To Vascular Surgeons Since They Already Use Heparin For Their Procedures
  Presenter(s):Joseph A. Caprini, MD  
  View Abstract      
7:49 AM - 7:54 AM Vein Diameter Is Not The Key For Stratifying Interventional Strategies For Superficial Venous Disease
  Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
7:55 AM - 8:00 AM Panel Discussion
END OF SESSION 64
 
SESSION 65 SCHEDULE
Thursday
SESSION 65: FIRST-LINE VENOUS IMAGING TECHNIQUES AND PHYSIOLOGIC TESTING
x
8:01 AM - 8:06 AM Duplex Mapping Done Correctly
  Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS  
  View Abstract      
8:07 AM - 8:12 AM What Information From Duplex Is Useful To Help Form A Treatment Plan? What Information Is Bogus But I’ve Seen Others Use Often
  Presenter(s):Neil M. Khilnani, MD  
  View Abstract      
8:13 AM - 8:18 AM Duplex Scanning Sourcing For Origin Of Reflux In Venous Ulcerations
  Presenter(s):Alfred M. Obermayer, MD  
  View Abstract      
8:19 AM - 8:24 AM Physiological Evaluation Of Venous Obstruction
  Presenter(s):Fedor Lurie, MD, PhD  
  View Abstract      
8:25 AM - 8:30 AM The Role Of IVUS In Stenting Of The Venous System
  Presenter(s):Stephen A. Black
, MD  
  View Abstract      
8:31 AM - 8:36 AM How To Measure Iliac Vein Stenosis
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
8:37 AM - 8:42 AM Shifting Paradigm Of Diagnosis And Treatment Of Suspected DVT (Role Of Non-Invasive Testing And Availability Of New Anticoagulants)
  Presenter(s):Fedor Lurie, MD, PhD  
  View Abstract      
8:43 AM - 8:48 AM Panel Discussion
END OF SESSION 65
 
SESSION 66 SCHEDULE
Thursday
SESSION 66: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
8:49 AM - 8:54 AM Endovenous Thermal Ablation RCTs: Do We Know Enough
  Presenter(s):Bo G. Eklof, MD, PhD  
  View Abstract      
8:55 AM - 9:00 AM Concomitant Treatment Of Truncal Reflux And Varicosed Tributaries Is The Gold Standard
  Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
9:01 AM - 9:06 AM The Argument Against Mandatory Duplex Scanning Following Vein Ablation
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Abstract      
9:07 AM - 9:12 AM Clarivein Versus Radiofrequency Ablation: The Results Of A RCT
  Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
9:13 AM - 9:18 AM Go Green: Avoid Synthetic Venous Ablation
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Abstract      
9:19 AM - 9:24 AM Reducing The Anxiety And Discomfort Of Patients Having Local Anesthetic Vein Treatments With Distraction Techniques And Hand Reflexology
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Abstract      
9:25 AM - 9:30 AM How Real Are Venous Thromboembolic Complications With Endovenous Thermal Ablation (The Paradox Between Data From Randomized Controlled Trials, Large Observational Case Series, And Registry Data)
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Abstract      
9:31 AM - 9:36 AM Different Options For Saphenous Vein Preservation
  Presenter(s):Paul Pittaluga, MD  
  View Abstract      
9:37 AM - 9:42 AM Does Superficial Venous Treatment (Open Or Endovenous) Help Venous Ulcer Healing
  Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg)  
  View Abstract      
9:43 AM - 9:48 AM Perforator Ablation: What Are The Indications
  Presenter(s):Peter F. Lawrence, MD  
  View Abstract      
9:49 AM - 9:54 AM Incidence Causes, And Treatment Of Recurrent Varicose Veins Following Endovenous Thermal Ablation
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Abstract      
9:55 AM - 10:00 AM Value Of Postoperative Compression After Mini-Invasive Surgical Treatment Of Varicose Veins
  Presenter(s):Paul Pittaluga, MD  
  View Abstract      
10:01 AM - 10:06 AM Is 1920 Nanometer Wavelength The Future Of Venous Ablation
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Abstract      
10:07 AM - 10:12 AM Panel Discussion
END OF SESSION 66
 
SESSION 67 SCHEDULE
Thursday
SESSION 67: WOUNDS, COMPRESSION, NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
x
10:13 AM - 10:18 AM Definition Of Venous Ulcer: Clinical Evaluation Wound Care, Compression, Surgical Treatment, Ancillary Measures And Primary Prevention
  Presenter(s):Marc A. Passman, MD  
  View Abstract      
10:19 AM - 10:24 AM Deep Venous Valve: When And Why
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
10:25 AM - 10:30 AM DOMINATE The Wounds System
  Presenter(s):Fedor Lurie, MD, PhD  
  View Abstract      
10:31 AM - 10:36 AM Sulodexide For Advanced Venous Disease
  Presenter(s):Joseph D. Raffetto, MD  
  View Abstract      
10:37 AM - 10:42 AM Venous Hemodynamic Revised – Valve Function And The Role Of Gravity
  Presenter(s):Fedor Lurie, MD, PhD  
  View Abstract      
10:43 AM - 10:48 AM The Importance Of Hemodynamics When Considering ASVAL
  Presenter(s):Sylvain Chastanet, MD  
  View Abstract      
10:49 AM - 10:54 AM What’s On The Horizon In Venous Thrombosis Research
  Presenter(s):Peter Henke, MD  
  View Abstract      
10:55 AM - 11:00 AM Panel Discussion
END OF SESSION 67
 
SESSION 68 SCHEDULE
Thursday
SESSION 68: VENOUS SOCIETAL AND GOVERNANCE ISSUES
x
11:01 AM - 11:06 AM A One Stop Vein Clinic: The Ideal Option?
  Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg)  
  View Abstract      
11:07 AM - 11:12 AM IAC Vein Center: Importance And Update
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Abstract      
11:13 AM - 11:18 AM Comparison Of The New SVS/AVF Venous Ulcer Guidelines To Other Venous Ulcer Guidelines
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Abstract      
11:19 AM - 11:24 AM Who Will Treat The Varicose Veins And Who Will Pay For It In The Future
  Presenter(s):Mark H. Meissner, MD  
  View Abstract      
11:25 AM - 11:30 AM Update On The SVS-PSO VQI Venous Registry
  Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS  
  View Abstract      
11:31 AM - 11:36 AM What Is The Future Of Venous Reimbursement
  Presenter(s):Glenn Jacobowitz, MD  
  View Abstract      
11:37 AM - 11:42 AM A National Coverage Determination Policy Is Needed
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Abstract      
11:43 AM - 11:48 AM Primary CVD: Which Patients Should You Intervene On Early (GSV Ablation, Correct Hemodynamics) And If You Intervene Will It Reduce Or Prevent The Progression To Higher Clinical Class
  Presenter(s):Joseph D. Raffetto, MD  
  View Abstract      
11:49 AM - 11:54 AM Why Standardization Is Needed With Endovenous Therapy
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Abstract      
11:55 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 68
 
SESSION 69 SCHEDULE
Thursday
SESSION 69: MEDICAL AND INTERVENTIONAL STRATEGIES FOR THROMBOEMBOLIC DISEASE
x
INTERVENTIONAL STRATEGIES
1:00 PM - 1:05 PM Benefit Of Early Thrombus Removal In DVT: How Should It Be Done; Endo Or Open
  Presenter(s):Bo G. Eklof, MD, PhD  
  View Abstract      
1:06 PM - 1:11 PM How Many Patients Will Be Suitable For Pharmaco-Mechanical Thrombolysis For Ilio- Femoral DVT
  Presenter(s):Stephen A. Black
, MD / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
1:12 PM - 1:17 PM Ward Based Catheter Directed Lysis
  Presenter(s):Stephen A. Black
, MD  
  View Abstract      
1:18 PM - 1:23 PM Early Thrombus Removal For Acute DVT: Does Tibial Access Help
  Presenter(s):Patrick E. Muck, MD, FACS  
  View Abstract      
1:24 PM - 1:29 PM Aspirational Thrombectomy For DVT: Role Of Angiovac And How It Will Change Practice
  Presenter(s):Firas F. Mussa, MD  
  View Abstract      
1:30 PM - 1:35 PM Catheter Directed Pulmonary Thrombolysis
  Presenter(s):Jason T. Salsamendi, MD  
  View Abstract      
1:36 PM - 1:41 PM Experience With 15 Consecutive Massive Pulmonary Embolism Patients And The Use Of The EKOS System
  Presenter(s):Luis R. Leon, MD, RVT, FACS  
  View Abstract      
1:42 PM - 1:48 PM Overview Of Current Role Of Lysis, Mechanical Thrombectomy And Stents For Acute And Subacute Iliofemoral And Caval DVT: What Is The Evidence In Support
  Presenter(s):Mark H. Meissner, MD  
  View Abstract      
1:49 PM - 1:54 PM Panel Discussion
MEDICAL STRATEGIES
1:55 PM - 2:00 PM P-Selectin Inhibition Therapeutically Promotes Thrombus Resolution And Prevents Vein Wall Fibrosis Better Than Enoxaparin And An Inhibitor To Von Willebrand Factor
  Presenter(s):Thomas W. Wakefield, MD  
  View Abstract      
2:01 PM - 2:06 PM How To Use The Newer Oral Anticoagulants: New Data Using Aspirin For Recurrent Venous Thromboprophylaxis
  Presenter(s):Timothy K. Liem, MD  
  View Abstract      
2:07 PM - 2:12 PM New Drugs For DVT Will Likely Replace Coumadin Derivatives
  Presenter(s):John Blebea, MD, MBA  
  View Abstract      
2:13 PM - 2:18 PM To Bridge Or Not To Bridge: That Is The Question
  Presenter(s):Joseph A. Caprini, MD  
  View Abstract      
2:19 PM - 2:24 PM The Role Of Metabolomics In DVT
  Presenter(s):Thomas W. Wakefield, MD  
  View Abstract      
2:25 PM - 2:30 PM DVT And PE In Infants And Children: Etiology, Diagnosis, Treatment And Prognosis
  Presenter(s):J. Leonel Villavicencio, MD  
  View Abstract      
2:31 PM - 2:36 PM D-Dimer And/Or Duplex Findings To Manage DVT
  Presenter(s):Timothy K. Liem, MD  
  View Abstract      
2:37 PM - 2:42 PM Panel Discussion
END OF SESSION 69
 
SESSION 70 SCHEDULE
Thursday
SESSION 70: CROSS-SECTIONAL VENOUS IMAGING TO CLARIFY DIFFICULT CLINICAL SCENARIOS
x
2:43 PM - 2:48 PM Dutch Approach To Magnetic Resonance Venography And Computed Tomographic Venography In Lower Extremity Chronic Venous Disease
  Presenter(s):Cees H.A. Wittens, MD, PhD  
  View Abstract      
2:49 PM - 2:54 PM American Approach To Magnetic Resonance Venography And Computed Tomographic Venography In Lower Extremity Chronic Venous Disease
  Presenter(s):Barry Stein, MD, FSIR, FACR  
  View Abstract      
2:55 PM - 3:00 PM MR Venography And Cone Beam CT, Compared To IVUS And Conventional Venography For Deep Venous Intervention
  Presenter(s):Rick De Graaf, MD, PhD  
  View Abstract      
3:01 PM - 3:06 PM Current Practice For MRV And CTV In Imaging Of Pelvic And Abdominal Venous Compressive Pathologies And Syndromes: Which Is Better And Why
  Presenter(s):Barry Stein, MD, FSIR, FACR  
  View Abstract      
3:07 PM - 3:12 PM A New Tool To Study The 3D Venous Anatomy Of The Human Embryo: The Computer Assisted Anatomical Dissection
  Presenter(s):Jean Francois Uhl, MD, FACPh  
  View Abstract      
3:13 PM - 3:18 PM Image Fusion With MRV For 3D Guidance Of Deep Venous Interventions
  Presenter(s):Rick De Graaf, MD, PhD  
  View Abstract      
3:19 PM - 3:24 PM The Use Of IVUS To Document May Thurner Anatomy
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Abstract      
3:25 PM - 3:30 PM Panel Discussion
END OF SESSION 70
 
SESSION 71 SCHEDULE
Thursday
SESSION 71: FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION, HOT IDEAS FOR RECANALIZING CHRONIC TOTAL OCCLUSIONS
x
3:31 PM - 3:36 PM Medical Treatment For Post-Thrombotic Syndrome
  Presenter(s):Thomas W. Wakefield, MD  
  View Abstract      
3:37 PM - 3:42 PM Good, Bad, Ugly Of The New Dedicated Venous Stents
  Presenter(s):Stephen A. Black
, MD  
  View Abstract      
3:43 PM - 3:48 PM Which Is More Important: Iliac Or Femoral Vein Stenosis
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
3:49 PM - 3:54 PM Management Of In-Stent Restenosis
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
3:55 PM - 4:00 PM How Knowledge Of Venous Embryology Can Help Establish Venous Outflow In Patients With Uncrossable Iliac Vein Obstruction
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
4:01 PM - 4:06 PM DEBATE: Common Femoral Endovenectomy, A/V Fistula, And Endoluminal Iliac Vein Recanalization Is Best For Establishing Inflow
  Presenter(s):Cees H.A. Wittens, MD, PhD  
  View Abstract      
4:07 PM - 4:12 PM DEBATE: Femoral Vein Recanalization Via Popliteal Access Establishes Better Inflow Than Common Femoral Vein Endovenectomy
  Presenter(s):Mark J. Garcia, MD  
  View Abstract      
4:13 PM - 4:18 PM IVC Recanalization In The Presence Of A Thrombosed IVC Filter
  Presenter(s):David M. Williams, MD  
  View Abstract      
4:19 PM - 4:24 PM Managing The Iliocaval Confluence With Interdigitating Z-Stents: Another Technique From The Mississippi Group One Must Learn
  Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS  
  View Abstract      
4:25 PM - 4:30 PM Value Of The Cutting Balloon In The Endovascular Treatment Of Post-Thrombotic Syndrome
  Presenter(s):David M. Williams, MD  
  View Abstract      
4:31 PM - 4:36 PM Update On EKOS “ACCESS DVT” Trial For Post-Thrombotic Syndrome
  Presenter(s):Mark J. Garcia, MD  
  View Abstract      
4:37 PM - 4:42 PM Achieving Inflow When The Femoral Vein And Profunda Femoris Vein Are Occluded
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
4:43 PM - 4:48 PM Crossing Femoro-Iliocaval Chronic Total Occlusions: Graduated Support And Tinkering
  Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS  
  View Abstract      
4:49 PM - 4:54 PM Re-Opening Occluded Femoro-Iliocaval Stents Using Aggressive Sharp Devices, Exploding Occluded Stents, Then Relining With New Stent
  Presenter(s):E. Brooke Spencer, MD  
  View Abstract      
4:55 PM - 5:00 PM Off Label Use Of Arterial CTO Devices For Crossing Venous CTOs
  Presenter(s):Constantino Pena, MD  
  View Abstract      
5:01 PM - 5:06 PM When Should I Stop Trying To Cross A Total Venous Occlusion
  Presenter(s):E. Brooke Spencer, MD  
  View Abstract      
5:07 PM - 5:12 PM Deep Venous Reconstruction
  Presenter(s):Marzia Lugli, MD  
  View Abstract      
5:13 PM - 5:18 PM What Conduit(s) And Why, Do I Chose For Deep System Reconstruction From Vena Cava To Iliac Veins?
  Presenter(s):Peter Gloviczki, MD  
  View Abstract      
5:19 PM - 5:24 PM Does Endovascular Treatment Work For Budd-Chiari Syndrome?
  Presenter(s):Byung-Boong Lee, MD  
  View Abstract      
5:25 PM - 5:30 PM Panel Discussion

End of Program I

END OF SESSION 71
 
SESSION 72 SCHEDULE
Thursday
SESSION 72: MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 1
x
72-A: 21ST CENTURY STROKE THERAPY PERSPECTIVES
8:00 AM - 8:09 AM Emergency Room Stroke Triage Issues And Solutions
  Presenter(s):Edward C. Jauch, MD, MS  
  View Abstract      
8:10 AM - 8:19 AM IV vs. IA Is Not The Argument: Revascularization Needs To Occur Early! How To Make It Happen
  Presenter(s):Mayank Goyal, MD, FRCPC  
  View Abstract      
8:20 AM - 8:29 AM 3 Trials Failed To Validate Acute Stroke Intra-Arterial Treatment: Why?
  Presenter(s):Don Frei, MD  
  View Abstract      
8:30 AM - 8:39 AM Update And Relevance Of Certification Of Comprehensive Stroke Centers
  Presenter(s):Steven H. Rudolph, MD  
  View Abstract      
8:40 AM - 8:49 AM Clinical Trials Update In Stroke Intervention
  Presenter(s):Michael D. Hill, MD  
  View Abstract      
8:50 AM - 8:59 AM Healthcare Policy Impact On Your Practice
  Presenter(s):Joshua A. Hirsch, MD  
  View Abstract      
9:00 AM - 9:10 AM Panel Discussion
72-B: STATE-OF-THE-ART IMAGING FOR STROKE
Moderator(s): Howard A. Rowley, MD /  R. Gilberto Gonzalez, MD, PhD  
9:10 AM - 9:19 AM Magnetic Resonance Stroke Imaging Protocol Fast And Efficient
  Presenter(s):Howard A. Rowley, MD  
  View Abstract      
9:20 AM - 9:29 AM CT And CTA Best Imaging Triage: The Calgary Way
  Presenter(s):Mayank Goyal, MD, FRCPC  
  View Abstract      
9:30 AM - 9:39 AM Penumbra, Collaterals, And New Data: Let’s Talk!
  Presenter(s): R. Gilberto Gonzalez, MD, PhD  
  View Abstract      
9:40 AM - 9:49 AM Imaging And Treatment Of Patients With Acute Stroke: An Evidence Based Review
  Presenter(s):Pina C. Sanelli, MD, MPH, FACR  
  View Abstract      
9:50 AM - 9:59 AM Pial Collaterals And The Capillary Index: Implications
  Presenter(s):Colin P. Derdeyn, MD  
  View Abstract      
10:00 AM - 10:09 AM Collaterals, Not Clots! CT Angiography Predictors Of Recanalization, And Clinical Outcomes After Thrombectomy
  Presenter(s):David S. Liebeskind, MD  
  View Abstract      
10:10 AM - 10:20 AM Panel Discussion
10:20 AM - 10:35 AM Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
72-C: CLINICAL SCENARIOS OF THE POSTERIOR CIRCULATION OF INTEREST
Moderator(s): Eugene S. Flamm, MD / Lou R. Caplan, MD  
10:35 AM - 10:44 AM The 5-Minute Neurological Exam
  Presenter(s):Daniel L. Labovitz, MD  
  View Abstract      
10:45 AM - 10:54 AM Posterior Circulation Stroke Syndromes And Territories